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Abstract 
Sodium-proton (Na+/H+) antiporters are secondary membrane protein transporters 
present in all living cells and are critical for sodium, pH and cell volume homeostasis. 
Their deregulation of transport activity has been linked to human diseases, such as, 
hypertension, heart failure and epilepsy and consequently they may be targets for 
drugs. In 2005, the first crystal structure of a Na+/H+ antiporter, NhaA from 
Escherichia coli, was solved at 3.45 Å resolution in an inward-facing conformation at 
pH 4 where the protein is inactive. Like many Na+/H+ antiporters, the activity of 
NhaA is regulated by pH and is active above pH 6.5. 
 
The main goal of this thesis was to solve a crystal structure of a Na+ /H+ antiporter in 
an active state. One of the problems in producing milligram quantities of purified 
membrane protein for crystallography is poor overexpression. For this reason, we first 
sought to improve membrane protein overexpression by developing a new expression 
platform, which we have called “MemStar” in E. coli using a test-case of control 
proteins, overall showing a boost in expression levels to at least 12 mg.L-1. 
 
This thesis describes the crystal structure of NapA from Thermus thermophilus, an 
NhaA homologue, which was solved to 3 Å in an outward-facing conformation at pH 
7.8 in an active state. This NhaA homologue was selected as purified protein could 
grow better diffracting crystals than NhaA. The stability of NapA was also more 
suitable for purification in a small micelle detergent to improve diffracting resolution. 
Although NhaA crystals did not form above pH 6.5, a stabilised mutant was useful to 
confirm the position of a critical residue important in the mechanism. 
 
Structural comparisons with the NapA structure show the core domain moving 
relative to the dimerisation domain, similar to a rocking bundle model observed in 
other structures of different secondary active transporters sharing conserved structural 
features in their membrane protein folds also present in NhaA and NapA. This work 
has provided us with a fresh insight into the mechanism of Na+/H+ antiporters. !
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Thesis Objectives 
 
The main objective of this thesis was to understand how sodium-proton antiporters 
function at the atomic level. X-ray crystallography was the method of choice for 
structural understanding and this information was combined with collaborative work 
from Dr. Christoph von Ballmoos (transport assays) and Dr. Oliver Beckstein 
(molecular dynamic simulations).  
 
Chapter 3 first describes an expression protocol that was developed to boost 
membrane protein production yields in E. coli to facilitate structural studies. This 
general expression protocol, MemStar, was later applied to structural studies of 
sodium-proton antiporters, as outlined in Chapters 4 and 5. 
 
Chapter 4 focuses on the bacterial sodium-proton antiporter NhaA from E. coli, which 
is the best characterised model system for sodium-proton antiport with both EM and 
crystal structures available. However, as only one crystal structure was solved at low 
pH where the protein is inactive, this has made it difficult to put together a transport 
mechanism. The practical objective was to try and improve the stability of NhaA to 
enable the growth of well ordered crystals above pH 6.5, where the protein is active. 
A random mutagenesis strategy was employed that improved the thermostability of 
NhaA. Although we did not manage to obtain an active state, nonetheless this 
approach did further improve the efficiency of growing well ordered crystals at low 
pH. This became an important issue as we uncovered that there had been an incorrect 
assignment of helix 10 on the original structure. 
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Chapter 5 describes the crystallographic work on NapA from Thermus thermophilus, 
a bacterial NhaA homologue, for which we were able to obtain well diffracting 
crystals grown in pH conditions where the protein is active. 
 
Structural comparisons were made against the inward-facing NhaA structure. Chapter 
6 gives a final discussion of what we have learnt from these structures with regards to 
the transport cycle of Na+/H+ antiport. 
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1.0 - 
Introduction 
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Introduction 
All living cells must exist in an isolated non-equilibrium system, which is maintained 
by a plasma membrane acting as a barrier to the external environment. The basic 
architecture of a membrane is a lipid bilayer composed from phospholipids. Each 
phospholipid contains two non-polar hydrophobic tails composed of acyl carbon 
chains situated in the interior with a polar hydrophilic phosphate head group facing 
the external aqueous environment. This arrangement creates a hydrophobic interior of 
the membrane that is selectively permeable to small lipophilic solutes or uncharged 
molecules (such as oxygen or carbon dioxide), but retards the diffusion of hydrophilic 
solutes and ions, which are essential for maintaining cellular homeostasis and thus 
cell survival. Facilitated transport of these polar molecules and ions across the 
selectively permeable membrane is carried out by integral membrane proteins (IMPs), 
which can span the membrane to provide a continuous protein-lined pathway through 
the lipid bilayer. 
 
1.1- Integral membrane proteins 
There are two major structural folds of IMPs present in bacteria and eukaryotes, 
namely the β-barrel or the α-helical bundle (figure 1.1). The β-barrel fold consists of 
a series of β-strands which hydrogen bond with neighbouring strands forming a 
closed pore-like structure (Schulz, 2000). This β-barrel structural fold is most 
common in the porin family of gram-negative bacteria for the transport of 
hydrophobic and hydrophilic molecules and extrusion of drugs by passive diffusion 
across the outer membrane (Nikaido, 2003; Hong et al., 2006). β-barrel IMPs are also 
found in the outer membranes of mitochondria in eukaryotes, reflecting their bacterial 
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origin. Here they are required for the transport of hydrophilic metabolites across the 
mitochondria outer membrane to and from the cytoplasm (Ujwal et al., 2008; Walther 
and Rapaport, 2009). 
 
The majority of membrane proteins are made up of α-helices with an average length 
of 25 amino acids and sufficient hydrophobicity to partition into the lipid bilayer and, 
in most cases, cross the membrane. These α-helical stretches are often referred to as 
transmembrane (TM) segments. They interact and associate with other TM segments, 
lipid and the bulk solvent to create many different types of structures, e.g., ion-
channels, G-coupled protein receptors (GPCRs) and transporters (Alberts, 2008). α-
helical IMPs are mostly present in the inner membrane of bacterial cells and plasma 
membrane of eukaryotes and make up 20-30 % of all sequenced genomes to date 
(Wallin and von Heijne, 1998). Human α-helical membrane proteins also represent 
40% of all pharmaceutical drug targets confirming their level of importance in all 
living cells (Overington et al., 2006). Henceforth, I use the term membrane proteins to 
denote α-helical membrane proteins. 
*&!!
 
 
(a)      (b) 
 
 
 
 
 
 
 
Figure 1.1 – Illustration of two types of integral membrane proteins. (a) An 
example of a β-barrel membrane protein (PDB: 1PHO, (Cowan et al., 1992)) and (b) 
an example of an α-helical membrane protein (PDB: 1PV6, (Abramson et al., 2003)). 
This and subsequent molecular structures are generated using Pymol (DeLano, 2002). 
 
 
1.2 - Membrane protein biogenesis 
Membrane proteins need to be transcribed, translated and translocated into the 
membrane bilayer. This is a multi-step process that must be managed to avoid protein 
misfolding and subsequent aggregation in the cytoplasm (figure 1.2) (Dalbey et al., 
2011). In Escherichia coli, membrane protein biogenesis begins when a hydrophobic 
α-helical segment is exposed from the exit tunnel of the ribosome and is recognised 
by the signal recognition particle (SRP) (Batey et al., 2000). SRP binding targets the 
ribosome nascent chain (RNC) complex to the inner membrane and docks onto the 
membrane bound SRP receptor, FtsY (Luirink and Sinning, 2004; Dalbey et al., 
2011). In eukaryotic cells, translation is halted when the SRP-RNC complex is 
formed and does not resume until it makes contact with the Sec61 translocon. 
Sufficiently hydrophilic α-helical TM segments pass laterally through the Sec 
translocon, whereas more polar ones pass through, as is the case for signal sequences 
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of secretory proteins. For membrane proteins the first TM segment is the signal 
sequence, which is generally not cleaved. α-helix partitioning into the membrane is 
mostly driven by favourable helix-lipid interactions (Hessa et al., 2007). In some 
cases very polar TM segments cannot insert by themselves, but may either be pulled 
into the membrane by neighbouring TMs, which are much more hydrophobic (Kauko 
et al., 2010) or by a cluster of downstream charged residues in keeping with the 
positive-inside rule where positively charged residues face the cytoplasmic side of the 
membrane (Heijne, 1986). Membrane protein topology predictions in E. coli and 
Saccharomyces cerevisiae show 80% of α-helical membrane proteins to have the C-
terminus facing the cytoplasm (CIN) (Rapp et al., 2004; Kim et al., 2006).  
 
 
 
Figure 1.2 – Illustration of membrane protein biogenesis. Membrane proteins fold 
co-translationally. After the signal sequence (shown in orange) exits the ribosome it is 
recognised by the SRP (step a). Binding of SRP halts further translocation in 
eukaryotes and the SRP-ribosome nascent chain complex is targeted to the SRP 
receptor, which is closely associated with the Sec translocon (step b). Translation 
resumes and TM segments pass laterally through an opening in the Sec translocon and 
into the membrane. This image is taken with permission from (Kang et al., 2013). 
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1.3 - Classes of membrane transport proteins 
 
Membrane transport proteins are essential for facilitated transport of hydrophilic 
molecules and ions that cannot otherwise cross the membrane passively. This is due 
to either their hydrophilic nature and/or because they are moving against a 
concentration gradient. There are two major classes of membrane transport proteins, 
namely channels and transporters. 
 
Channels are understood to simply act as a selective “passageway” through the 
membrane. Ion channels carry out passive transport by opening a pore through the 
middle of the protein for ions to diffuse down their concentration gradient in keeping 
with the Nernst potential (Gouaux and Mackinnon, 2005). Channel pores act as 
selective filters that will only allow certain types of ions to pass through depending on 
their size, shape, and charge (Zhou et al., 2001). Different types of stimuli can also 
modulate a channel to open and close, such as ligands (neurotransmitters) or changes 
in membrane potential. 
 
Membrane transporters, in contrast, specifically bind to a given molecule (substrate) 
and physically undergo a “bind and release” conformational change to transport the 
substrate across the membrane. Active transport requires an energy source to transport 
molecules and ions against their concentration gradients across the membrane, which 
is critical for all living cells, as they exist in a non-equilibrium state. Primary active 
transporters use a direct energy source to drive conformational changes to transport 
molecules across the membrane, such as ATP hydrolysis. For example the 
sodium/potassium (Na+/K+) ATPase exchanges 3Na+ (out) for 2K+ (in) to maintain the 
electrochemical potential used to drive action potentials and consumes 20% of ATP 
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production at rest (Silver and Erecinska, 1997). Secondary active transporters utilise 
the energy stored in ion gradients. Movement of ions down their electrochemical 
gradients is used to transport substrates against their concentration gradient across the 
membrane (figure 1.3). Membrane symporters transport the ion and substrate in the 
same direction across the membrane and membrane antiporters transport the 
components in opposite directions. Membrane uniporters share similar kinetic 
characteristics to symporters and antiporters, but instead undergo passive transport of 
one substrate species down its concentration gradient, as shown from the family of 
glucose transporters (GLUT family), which are present on the plasma membranes of 
human erythrocytes for concentration dependent glucose uptake (Gould and Holman, 
1993). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 – Schematic illustration of two types of secondary active transporters. 
From left to right, a membrane symporter simultaneously transports its substrate 
across the membrane in the same direction as the electrochemical gradient of its co-
transported ion used as an energy source. A membrane antiporter transports its 
substrate across the membrane in the opposite direction of the electrochemical 
gradient of the counter-ion. 
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Secondary active transporters have been proposed to function by an alternating access 
mechanism, involving structural movements to take place during transport to form an 
‘outward-facing' state when the substrate binding site is accessible and open to the 
external medium and an ‘inward-facing' state where the protein is open towards the 
cytoplasm (Jardetzky, 1966). In the last ten years, a number of high resolution crystal 
structures from bacterial homologues of different Na+- and H+-coupled transporters 
have been solved in the inward and outward states as well as intermediate states 
where the substrate binding site is not accessible to bulk solvent on either side of the 
membrane; referred as the occluded state (figure 1.4). 
 
 
 
Figure 1.4 – Schematic illustration of the alternating access mechanism. From left 
to right, an outward-facing conformation is present for the substrate and co-
transported ion to enter a central binding site from the extracellular space. An 
occluded state is followed with conformational changes taking place to first seal off 
access of the binding site to both sides of the membrane. The protein switches to the 
inward-facing conformation with the binding site solvent exposed to the cytoplasm to 
release the substrate and co-transported ion. With membrane antiporters, the counter-
ion is co-transported in the opposite direction to the substrate. 
 
 
co-transport-ion!substrate!
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Outward-facing!
Out!
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The solute carrier transporter (SLC) superfamily comprises over 300 identified 
secondary active transporters, classified into 55 SLC gene families based on their 
sequence and function in the co-transport of essential nutrients, such as sugars, amino 
acids, nucleosides, neurotransmitters, cofactors (vitamins and metal ions), drugs and 
ions (Saier et al., 2006). In the last ten years a cumulative increase in the number of 
high resolution crystal structures of secondary transporters has helped to narrow the 
gap between the concepts of secondary transport and understanding how the 
alternating access mechanism is established at the molecular level. 
 
Different structural themes are also emerging as more structures are being solved 
from secondary transporters in different SLC families. Firstly, a number of structures 
with diverse functions have been observed to show similarities in their structural fold. 
This especially true for the LeuT fold superfamily containing multiple structures 
solved in the same/different conformations from 7 different SLC families, all 
classified to share the LeuT fold (Yamashita et al., 2005; Faham et al., 2008; Weyand 
et al., 2008; Fang et al., 2009; Ressl et al., 2009; Shaffer et al., 2009; Tang et al., 
2010). Secondly, all secondary transporter structures solved to date show topology-
repeat units that can form separate structural domains parallel to the membrane, as 
observed with transporters in the major facilitator superfamily (MFS) (Abramson et 
al., 2003; Huang et al., 2003) or inverted domains related by pseudosymmetry 
perpendicular to the membrane, as observed with transporters of the LeuT, GltPh 
(Yernool et al., 2004) and NhaA (Hunte et al., 2005) folds as well as within the 
separate domains of MFS transporters (Radestock and Forrest, 2011). The 
pseudosymmetry observed between these repeat units has been suggested to facilitate 
switching between the outward and inward-facing states. Through structural 
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comparison of the same or similar proteins solved in multiple conformations, crystal 
structures play a significant part in helping us to better understand the molecular basis 
of the alternating access mechanism. A common structural theme seen among a 
number of secondary transporters is the movement of two structural domains that rock 
against one another to promote alternate access of a central substrate binding site 
between the inward and outward states (Forrest et al., 2011). 
 
This thesis focuses on the SLC9 Sodium-proton (Na+/H+) exchanger family. 
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2.0 –  
Sodium-Proton Antiporter family 
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2.1 - Physiological roles of sodium-proton antiporters 
The presence of electrochemical gradients of sodium ions (Na+) and protons (H+) 
across the cell membrane is critical for all living cells to provide an energy source for 
secondary active transport of cellular solute and ion uptake as well as ATP synthesis 
(Skulachev, 1991). Sodium-proton (Na+/H+) antiporters are essential for regulating 
sodium and pH homeostasis and are subsequently driven by these electrochemical 
gradients depending on the cell type (figure 2.1). Consequently their deregulation can 
cause the intracellular concentration of both ions to become potent, leading to cellular 
stress and eventually cell death. 
 
 (a) 
 
 
 
 
 
 
 
 (b) 
 
 
 
 
 
 
 
 
 
Figure 2.1 – Schematic illustration of Na+/H+ antiport activity and movement of 
H+ and Na+ ions across the cell membrane. Na+/H+ antiporters play an important 
role in cell homeostasis in all living cells by converting a generated proton motive 
force (PMF) into a sodium motive force (SMF) and vice versa to maintain the 
function of H+-coupled and Na+-coupled transporters for the transport of essential 
solutes and ions across cellular and organelle membranes. (a) Prokaryotic Na+/H+ 
antiporters are driven by a PMF generated from oxidative phosphorylation. (b) 
Eukaryotic Na+/H+ antiporters are mostly driven by a SMF generated from Na+/K+ 
ATPase activity. This figure is adapted from (Hase et al., 2001). 
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The transport activity of Na+/H+ antiporters was first discovered by Peter Mitchell and 
Ian West in 1974, who showed in E. coli that after the addition of Na+ ions to the 
bacterial cells, an efflux of Na+ ions is driven by the proton motive force (PMF) (West 
and Mitchell, 1974). Since then, their transport activity has been identified in the cell 
membranes of bacteria, yeast, plants and animals as well as organelle membranes, 
such as mitochondria and plant vacuoles (Brett et al., 2005). Although the antiport 
exchange of Na+ and H+ ions is conserved across all species, their physiological roles 
show more variation depending on the cell type and surrounding environment. 
 
Bacterial Na+/H+ antiporters 
In bacteria, Na+/H+ antiporters present on the inner membrane play central roles in the 
regulation of internal Na+ and H+ concentrations necessary for cell survival, by 
exporting excess intracellular Na+ ions using the PMF generated by oxidative 
phosphorylation (figure 2.1) (Padan and Schuldiner, 1994). Their function has been 
shown to be particularly important in preventing cellular alkalidosis under 
environmental conditions of extreme salt stress and high pH. Bacterial Na+/H+ 
antiporters are also shown to have an important constructive role in using the free 
energy from the PMF to generate a sodium motive force (SMF) to drive Na+-coupled 
secondary transporters for the uptake of sugars, amino acids, nucleosides and ions as 
well as drive Na+ -coupled drug efflux systems (Padan and Schuldiner, 1994; Padan et 
al., 2005). E. coli NhaA has been the most functionally characterised bacterial Na+/H+ 
antiporter and carries out electrogenic transport in a 2H+:1Na+ ratio, also observed 
from other bacterial NhaA homologues (Padan et al., 1989; Inoue et al., 1999; Furrer 
et al., 2007). E. coli NhaA was also the first Na+/H+ antiporter to be solved by X-ray 
crystallography (Hunte et al., 2005) and therefore will be further discussed. 
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Mammalian Na+/H+ antiporters 
 
Mammalian Na+/H+ antiporters (often referred to as NHEs) consist of a family of 
gene-related isoforms (NHE1-9), sharing ~25-70% amino acid identity overall, but 
differing in their physiological functions, depending on their location in the plasma 
and/or intracellular membrane and cell type (Orlowski and Grinstein, 2004). 
 
Plasma-membrane type NHEs are important for regulating intracellular pH, cell 
volume and preventing cellular acidification by exporting excess H+ ions from the 
cytoplasm using the SMF generated by Na+/K+ ATPase (figure 2.1) (Demaurex and 
Grinstein, 1994; Counillon and Pouyssegur, 2000). By controlling cell volume and 
maintaining cellular and organellar pH, mammalian NHEs have been proposed to 
play pivotal roles in numerous physiological processes, including transepithelial ion 
transport, cell proliferation and apoptosis, cell migration and vesicle trafficking 
(Orlowski and Grinstein, 2004). Consequently their loss of regulated activity has been 
shown in different human diseases, such as cancer, diabetes, cardiovascular disease, 
hypertension and organ ischemia (Putney et al., 2002; Bobulescu et al., 2005). Human 
NHE1 in particular has been the most extensively studied isoform expressed on all 
cell types and regulates cell proliferation and apoptosis (Slepkov et al., 2007), making 
it a major drug target in human diseases, such as cardiovascular disease and breast 
cancer (Lee et al., 2012; Amith and Fliegel, 2013). In contrast, the transport activity 
of the NHE3 isoform expressed on the apical surface of intestinal epithelial cells is 
critical for generating a PMF, driven by a SMF generated from the basolateral Na+/K+ 
ATPase, for the absorption amino acids, oligopeptides, metal ions and drug 
compounds by apical H+-coupled secondary transporters (Thwaites and Anderson, 
2007). This dual ion transport activity network between the apical NHE3 and 
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basolateral Na+/K+ ATPase is also present in the kidneys for the reabsorption of 
filtered solutes and ions by H+-coupled transporters (Bobulescu and Moe, 2009). The 
NHE6 isoform located on the inner mitochondrial membrane also uses a PMF 
generated by oxidative phosphorylation to export excess matrix Na+ ions to regulate 
the mitochondrial volume and pH (Numata et al., 1998). NHE6 is also involved in 
maintaining mitochondrial calcium homeostasis, which is very important for 
metabolic regulation, with excess Ca2+ ions exported by Na+/Ca2+ antiporters utilising 
a SMF generated from the NHE6 activity (Bernardi, 1999). Unlike their bacterial 
orthologues, mammalian NHEs are understood to carry out electroneutral antiport 
exchange (1H+:1Na+)(Demaurex et al., 1995). 
 
Plant Na+/H+ antiporters 
Plant vacuolar Na+/H+ antiporters (NHX) are very important for plant agriculture to 
prevent salt stress and confer halotolerance by compartmentation of excess Na+ from 
the cytoplasm into vacuoles using a PMF generated by the vacuolar H+-ATPase 
(Rodriguez-Rosales et al., 2009). Subsequently, transgenic Arabidposis plants 
overexpressing the NHX1 gene from Arabidopsis thaliana have enhanced salt 
tolerance (Apse et al., 1999). The SOS1 family is also another important class of plant 
Na+/H+ antiporters located on the plasma membrane for sodium extrusion (Nunez-
Ramirez et al., 2012). 
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2.2 - Cation proton antiporter superfamily 
All sequenced Na+/H+ antiporter genes have been classified into the monovalent 
cation proton antiporter (CPA) superfamily; containing other secondary transporters 
involved in cation regulation and pH homeostasis by the exchange of Na+, Li+ or K+ 
for H+ ions (Brett et al., 2005; Saier et al., 2006). Based on phylogenetic analysis, 
Na+/H+ antiporters from bacteria, plants and humans in the CPA superfamily are 
divided into two main branches, the CPA1 and CPA2 families; shown in figure 2.2 
(Brett et al., 2005). 
 
CPA1 family 
The CPA1 family evolved from bacterial NhaP genes, which encode for a family of 
Na+/H+ antiporters that carry out pH-dependent electroneutral transport of Na+ or Li+ 
ions using the PMF (Hellmer et al., 2002). These ancestral bacterial NhaP genes are 
shown to have evolved and diverge into two gene clusters; the NhaP-SOS1 clade, 
containing multiple paralogues of the bacterial NhaP family sharing homology with 
the plant SOS1 Na+/H+ antiporter family and the eukaryotic NHE clade containing the 
mammalian NHE isoforms and plant vacuolar NHX family (Brett et al., 2005). 
 
Sequence homology between the mammalian NHEs also reflects their subcellular 
localisation in the plasma membrane (isoforms 1-5) and intracellular membrane 
(isoforms 6-9) sharing 25–70% amino acid identity overall (Orlowski and Grinstein, 
2007). All Na+/H+ antiporters in the CPA1 family are understood to carry out 
electroneutral exchange according to the transport classification database 
(http://www.tcdb.org/)(Saier et al., 2006). 
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Figure 2.2 – Phylogenetic distribution of bacterial and eukaryotic members from 
the CPA superfamily. The unrooted dendrogram shows phylogenetic relationships 
between 22 selected CPA sequences from sequenced genomes according to the NCBI 
Taxonomy database (Wheeler et al., 2000). The coloured bars on the right indicate 
classification into the CPA1 and CPA2 families, which can be further subclassified: 
CPA2 is divided into the CHX and NHA clades and CPA1 is divided into the NhaP-
1/SOS1, plasma-membrane (PM)-NHE and intracellular (IC)-NHE clades. 
Phylogenetic analysis was carried out in ClustalW Phylogeny and displayed using the 
ATV software (Zmasek and Eddy, 2001). 
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CPA2 family 
 
The CPA2 family is smaller than CPA1 and contains both Na+/H+ and K+/H+ 
antiporter genes from bacteria, fungi, plants and animals (Brett et al., 2005). It is 
understood that gene origin of this family is shared between two bacterial ancestral 
Na+/H+ antiporters genes, NhaA and NapA, and the bacterial K+/H+ antiporters KefB 
and KefC required for K+ ion export to regulate intracellular pH during metabolite 
detoxification (Goldberg et al., 1987; Waser et al., 1992; Ferguson et al., 1993; Furrer 
et al., 2007). Bacterial homologues of NhaA and NapA are both shown to conserve 
pH-dependent electrogenic transport (Taglicht et al., 1993; Furrer et al., 2007). The 
CPA2 family is divided into two gene clusters; the CHX clade branching from the 
bacterial NapA and Kef genes and the NHA clade branching from only the bacterial 
NhaA genes. Unlike the CPA1 family, there are fewer CPA2 animal Na+/H+ 
antiporters with members not functionally characterised (Brett et al., 2005). In the 
NHA clade, the bacterial NhaA genes share homology with the fungal NHA family 
(Na+, K+/H+), and a more recently identified animal NHA Na+/H+ antiporter family. 
To date only two human NHA genes have been identified, NHA1 and NHA2, 
compared to the more studied human NHE genes of the CPA1 family (Ye et al., 2006; 
Xiang et al., 2007), with the functional activity of the NHA2 isoform linked to pH 
and salt homeostasis in the kidneys and essential hypertension (Canessa et al., 1980; 
Fuster et al., 2008; Kondapalli et al., 2012). 
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2.3 - Escherichia coli NhaA 
E. coli NhaA from the CPA2 family has been the most extensively studied Na+/H+ 
antiporter and has become a model-representative of a pH-regulated Na+/H+ antiporter, 
particularly after it was the first crystal structure of a Na+/H+ antiporter to be solved in 
2005 (Padan et al., 2004; Hunte et al., 2005). 
 
The transport activity of NhaA was first identified in the 1980s from an E. coli mutant 
strain, which showed increased Na+/H+ activity due to a mutation in a gene (nhaA) 
that was sequenced to encode a Na+/H+ antiporter that extrudes Na+ or Li+ ions in 
exchange for a H+ ion (Goldberg et al., 1987; Karpel et al., 1988; Taglicht et al., 
1991). Cell expression of NhaA is regulated by a positive regulator, nhaR, which is 
induced by intracellular Na+ or Li+ ions with its transport activity strictly regulated by 
intracellular pH and shown to increase by three orders of magnitude from pH 6.5 to 
8.5 in the presence of both ions (Karpel et al., 1991). By using salt-sensitive E. coli 
mutant strains, NhaA was confirmed to be indispensible for cell growth under 
extreme alkaline and high salt conditions (0.6 M NaCl or 0.1 M LiCl both at pH 8.5), 
with increased expression and an exceptionally fast turnover rate of 100,000 ions per 
minute to prevent cellular alkalidosis (Taglicht et al., 1991, 1993). 
 
2.4 – NhaA structure 
Ten years after the nhaA gene was discovered, the first structural insight of the NhaA 
antiporter was made by electron microscopy (EM)!(Williams et al., 1999). Cryo-EM 
analysis of 2D crystals showed NhaA as a dimer with two monomers containing 12 
TMs (Williams et al., 1999; Williams, 2000). An NhaA dimeric state was later 
confirmed by biochemical cross-linking and genetic complementation experiments 
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using native membranes under the extreme salt stress conditions when NhaA is 
functionally most active (Gerchman et al., 2001). 
 
Four years later, an NhaA crystal structure was solved at 3.45 Å in an inward-facing 
conformation from crystals grown at low pH where the protein is inactive (figure 
2.3)(Williams et al., 1999; Hunte et al., 2005). Although the protein was not 
crystallised as a physiological dimer, alignment of the X-ray and cryo-EM electron 
density maps show the same helix positions, confirming the crystal structure to 
represent a native conformation (Screpanti et al., 2006). 
 
The structure of the NhaA monomer shows an NIN - CIN topology with TMs 1 to 5 and 
TMs 8 to 12 related by a pseudo two-fold axis of symmetry parallel to the membrane 
plane and are separated by TMs 6 and 7 (figure 2.3, part a) (Hunte et al., 2005). In 
agreement with the EM and cryo-EM maps, two densely packed domains are formed 
by these two inverted topology repeats intertwining to form a dimerisation (interface) 
domain and a six-helical bundle core domain (figure 2.3, part b and c). After fitting 
the X-ray monomeric structure onto the cryo-EM map, it can be seen that the two 
adjacent β-hairpin motifs on the periplasmic side (between TMs 1 and 2) from both 
monomers form an antiparallel four-stranded β-sheet (figure 2.3, part c) (Appel et al., 
2009). 
 
This β-hairpin motif is critical for dimerisation but not for transport activity 
depending on the external cell growth conditions (Rimon et al., 2007). From 
complementation growth assays using salt-sensitive E. coli mutant strains, the wild 
type NhaA dimeric state has shown to complement cell growth better under extreme 
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salt stress conditions (0.1 M LiCl pH 7 or 0.6 M NaCl pH 8.5) and is also more 
thermostable compared to an NhaA monomer mutant with a deletion of only the β-
hairpin motif (Herz et al., 2009). 
 
 
(a) 
 
 
 
 
 
 
(b)      (c) 
 
 
 
 
 
 
 
 
Figure 2.3 – Structure of Escherichia coli NhaA. (a) Two inverted topology repeats 
of TMs 1 to 5 (blue) and TMs 8 to 12 (red) related by a pseudo two-fold axis of 
symmetry parallel to the membrane plane. (b) Structure viewed in the membrane 
plane coloured as a rainbow from the N terminus (red) to the C terminus (blue). (c) 
Structure of NhaA dimeric model (Appel et al., 2009) viewed from the extracellular 
side. Mol A shows the core domain (TMs 3,4,5,10,11 and 12) coloured dark blue and 
the dimer domain (TMs 1,2,8 and 9) coloured beige which are connected by TMs 6 
and 7 coloured grey. Mol B shows the same helix colour scheme as part (b). All 
structures are shown as a cartoon representation. Unless otherwise stated the colour 
scheme of NhaA in part (b) is applied henceforth. 
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NhaA fold 
The NhaA structure introduced a new structural fold of a secondary transporter based 
on the arrangement of TMs 4 and 11 in the core domain (figure 2.4, part a) (Hunte et 
al., 2005). These helices are antiparallel and often termed “discontinuous” due to the 
presence of extended peptide chain regions in the middle where they cross over with 
each other in the centre of the core domain. Close to these extended peptide chains are 
two highly conserved aspartic acid (Asp) residues, Asp163 and Asp164, from TM 5, 
of which transport activity is abolished when their carboxylate groups are removed 
and therefore likely to be involved in sodium binding (Inoue et al., 1995). A deep 
narrow cytoplasmic funnel-like cavity and an oppositely facing shallow periplasmic 
cavity is also present showing these two aspartate residues located at the bottom of 
both cavities in the middle of the membrane, further supporting this extended peptide 
region to be the location of the ion binding site. The cytoplasmic-facing cavity is lined 
with negatively charged residues likely to attract hydrated sodium ions to move down 
towards the ion binding site for transport. These two aspartate residues are strictly 
conserved across all CPA2 bacterial and human NHA homologues with a similar loss 
of transport activity if either residue is removed (figure 2.4 part b) (Tsuboi et al., 
2003; Furrer et al., 2007; Xiang et al., 2007). Similarly bacterial and human NHE 
homologues from the CPA1 family strictly conserve one aspartate residue equivalent 
to Asp164 from NhaA, which has also been confirmed from the NHE1 isoform to be 
essential for transport activity (Murtazina et al., 2001; Ding et al., 2006). 
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Figure 2.4 – Core domain of NhaA. (a) Cartoon representation of the core domain 
with the same coloured helices (as shown in Figure 2.3, part b) viewed from the 
periplasmic-facing side of the membrane. Essential ion binding residues Asp163 
(D163) and Asp164 (D164) from TM 5 are located in the ion binding site with critical 
residues Asp133 (D133) from the peptide region to charge-compensate the opposing 
positive N-termini of TMs 4b and 11b and similarly Lys300 (K300) from TM10 for 
the opposing negative C-termini of TMs 4a and 11a. (b) Sequence alignment of 
bacterial and eukaryotic Na+/H+ exchangers from the CPA1 and CPA2 families. For 
clarity only parts of TMs 4, 5 and 10 are shown. The ion binding residue equivalent to 
Asp164 in NhaA on TM 5 is strictly conserved across both families as well as a 
positively charged residue aligning with Lys300 on TM 10 of NhaA. Asp133 on TM 
4 of NhaA is only conserved across bacterial and eukaryotic Na+/H+ antiporters of the 
CPA1 family. Multiple sequence alignment was carried out in ClustalW and the 
MAFFT server in JalView with the sequences coloured in ClustalW format. 
 
 
The ion binding site contains regions of opposing positive and negative charges from 
the antiparallel N- and C-termini of TMs 4a-b and 11a-b, which from the structure are 
proposed to be stabilised by Asp133 from TM 4 and lysine (Lys) 300 from TM 10 
respectively. Both residues are confirmed to be important for transport in the ion 
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binding site and conserved across bacterial and human homologues (figure 2.4, part 
b)(Inoue et al., 1995; Kozachkov et al., 2007).  
 
Based on the NhaA structure in combination with functional analyses, it has been 
proposed that when E. coli cells are exposed to extreme conditions of high salinity 
and pH, electrogenic transport exchange in NhaA is up-regulated by the nhaR 
regulator upon high intracellular Na+ concentrations with the deprotonation of Asp163 
and Asp164 in the ion binding site to export one sodium ion into the periplasm with 
the release of their protons into the cytoplasm. Other experimental techniques have 
indirectly confirmed the presence of a pH-induced conformational change of NhaA 
when it is likely to be active, such as the use of monoclonal antibodies (Venturi et al., 
2000), accessibility to trypsin!(Rothman et al., 1997) and fluorescent probes!(Tzubery 
et al., 2004). Difference cryo-EM maps have also more recently observed helical 
movements in the core domain when higher pH buffers (with/without Na+ ions) are 
added to 2D NhaA crystals grown at low pH (Appel et al., 2009). 
 
However, the single NhaA structure to date is still the only structural model of a 
Na+/H+ antiporter in the Protein Data Bank (PDB), which makes it difficult to identify 
the specific movements of the helices at the molecular level during pH activation and 
transport activity in Na+/H+ antiporters. Given that NhaA has the fastest reported 
turnover rate of a secondary transporter, it has been proposed that the transport 
mechanism will involve small helical movements in the core domain rather than large 
movements across the whole protein (Padan et al., 2009). 
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To try and answer these questions, the main aim of this thesis was firstly to solve an 
NhaA structure under conditions where the protein is active and, ideally, in a different 
conformation to the inward-facing inactive state (Padan et al., 2004). The most likely 
reason why an NhaA active structure has still not been solved is due to reduced 
stability in a detergent solution. The most common approach to solving a membrane 
protein structure by crystallography has been through the use of detergents, as a 
substitute for the lipid bilayer during protein purification, but this can affect the native 
folded state; this is discussed further in the following section. 
 
At the start of my PhD, two approaches had been taken to address this issue. Firstly 
the detergent stability of NhaA was investigated to determine the best possible 
solution for optimising its stability for crystallisation in an active pH condition. The 
second approach was to screen more bacterial homologues of NhaA from 
thermophilic bacteria, which are likely to be more naturally stable than NhaA and 
thus may be more stable under the unnatural and harsh conditions used for protein 
crystallisation. 
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2.5 - Working with membrane proteins 
X-ray crystallography has been the most successful technique for high resolution 
structural determination of IMPs, of which 387 unique membrane protein structures 
have to date (March 2013) been reported in the database “Membrane proteins of 
known structure” (White, 2009). The general approach to solve a membrane protein 
structure using X-ray crystallography is to first overexpress the target protein to 
milligram quantities for purification using detergents to substitute the lipid bilayer and 
keep the membrane protein in its native folded state. From the exposed hydrophilic 
loop regions protein-protein interactions can be made to initiate crystal growth. As 
this treatment forces the transfer of a folded membrane protein from its natural lipidic 
membrane environment into an unnatural environment during crystallisation, it is 
crucial that the membrane protein is not partially unfolded which will result in protein 
aggregation. This is the major reason why membrane proteins represent only 0.005% 
of all protein structures in the PDB, reflecting the technical difficulties associated 
with structural studies of membrane proteins (Carpenter et al., 2008).  
 
Membrane protein overexpression is commonly known to produce inclusion bodies 
due to oversaturation of the Sec-translocation machinery resulting in cellular toxicity. 
Unlike β-barrel membrane proteins, α-helical membrane proteins are most often 
overexpressed and extracted from the cell membranes. To prevent the membrane 
protein unfolding during membrane extraction, the detergent n-dodecyl β-D-maltoside 
(DDM) is often the first detergent choice for purification as it contains a long 
hydrophobic CH2 chain with a large uncharged maltoside head group; therefore 
considered mild and less likely to destabilise the protein. Detergents stabilise the 
folded membrane protein as a protein-detergent micelle, provided the detergent 
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concentration is above its critical micelle concentration (CMC). The problem with 
using the relatively large DDM detergent is that it can mask the hydrophilic surface of 
membrane proteins needed for protein-protein interactions for crystal growth, 
especially with secondary transporters that do not contain intracellular or extracellular 
domains. Small micelle detergents containing shorter hydrophobic chains and/or 
smaller head groups are an alternative choice to optimise crystal packing. The head 
group can also remain uncharged such as β-octyl-glucoside (β-OG), or charged such 
as N,N-Dimethyldodecylamine N-oxide (LDAO); considered to be a harsh detergent. 
The use of small micelle detergents is statistically more likely to result in membrane 
crystals diffracting to a higher resolution compared to DDM (Sonoda et al., 2010). 
However if the membrane protein cannot remain stable in a small micelle detergent, it 
will unfold and aggregate. 
 
One of the best approaches to take at the first stages of a membrane protein 
crystallography project is to screen for the most stable membrane protein candidates 
or homologues, which are more likely to produce high resolution diffracting crystals 
using a small micelle detergent. Stability screens have since been introduced to 
monitor intrinsic stability in a detergent micelle (Sonoda et al., 2011), but is still 
dependent on the membrane protein overexpression yields to produce milligram 
amounts of high quality pure protein for crystallisation. In other words if a membrane 
protein target is known to remain stable in a small micelle detergent, low expressions 
levels can result in over-concentrating free detergent micelles during purification and 
hinder crystallisation. For this reason, method developments to optimise membrane 
protein expression were also carried out in this thesis. 
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3.1 - Introduction 
As outlined in chapter 1, one of the important parameters for obtaining well-
diffracting crystals for solving membrane protein structures is their stability in 
detergent solution (Serrano-Vega et al., 2008; Sonoda et al., 2010; Bill et al., 2011). 
In general, the better the stability of the membrane protein in a small micelle 
detergent, the easier it is to optimise crystals as it increases the number of potential 
crystal contacts. However, the problem encountered with screening membrane 
proteins based on stability, such as GPCRs, is that it does not correlate with 
overexpression levels (Shibata et al., 2009; Sonoda et al., 2011).!As such, many of the 
most detergent stable membrane proteins may only be produced to low levels and the 
extra financial cost associated with purification in small micelle detergents can make 
them practically infeasible to work with.!
 
Our goal was to determine an active-state structure of a Na+/H+ antiporter. As will 
later be discussed in Chapter 5, bacterial NhaA homologues were screened to try and 
identify a naturally more stable homologue at active pH. Unfortunately, however, the 
expression levels were quite poor and we needed to improve overexpression levels of 
the best target to facilitate cost-effective purifications in small micelle detergents. 
Despite published papers already describing new methodologies shown to improve 
membrane protein expression yields, it is still considered to be a matter of “trial and 
error” to find a good combination of different parameters to obtain high membrane 
protein overexpression levels, e.g., such as the type of promoter, strain, fusion tag, 
media and culture conditions (Wang et al., 2003). Our approach was to firstly identify 
an optimum type of medium, as this is the easiest parameter to first adjust. 
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One common feature observed with optimised expression conditions for membrane 
protein production is the use of an auto-induction medium (Deacon et al., 2008). For 
this reason we started our approach by testing different auto-induction media. 
 
In general, the E. coli Walker strains C43(DE3) and C41(DE3) are considered the best 
suited for membrane protein production in E. coli. The Walker strains have mutations 
in the lacUV5 promotor site, which reduce the levels of T7 RNA polymerase activity 
and this minimises over-saturation of the Sec-translocon (Miroux and Walker, 1996; 
Wagner et al., 2008). As such, membrane protein overexpression is generally less 
toxic in comparison to BL21(DE3) strains. Both strains have been successful in 
optimising membrane protein expression from large-scale expression screening 
studies (Korepanova et al., 2005; Hammon et al., 2009). More recently the 
Lemo21(DE3) strain was developed to regulate the T7 RNA polymerase activity by 
controlling the expression of its natural inhibitor T7 lysozyme (Wagner et al., 2008; 
Schlegel et al., 2012). In the method outlined in this chapter, both C43(DE3) and 
Lemo21(DE3) strains were tested in combination with the different types of media. 
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3.2 - Materials and methods 
A detailed step-by-step protocol of the GFP-based overexpression and purification 
pipeline used in E. coli is given in Drew et al., 2006. 
 
3.2.1- Expression strains and plasmid 
E. coli expression strains C43(DE3) and Lemo21(DE3) were used in this chapter 
(Miroux and Walker, 1996; Wagner et al., 2008). All control proteins were cloned in 
a pWaldo-GFPe vector (Drew et al., 2006). This expression plasmid was derived from 
the pET28(+) vector with the expression cassette under the transcriptional control of 
the T7 promotor using kanamycin selection. This vector is modified with a C-terminal 
green fluorescent protein (GFP) fusion containing an 8 x Histidine tag. A TEV 
protease recognition site is situated between the membrane protein template and GFP-
His8 tag for removal of the latter tag (Drew et al., 2006). Transformations and 
expression culture conditions were supplemented with 50 µg/mL kanamycin and 30 
µg/mL chloramphenicol when using the Lemo21(DE3) strain. 
 
$$!!
 
3.2.2 – Types of media 
Luria Broth (LB) and two auto-induction media, ZYM-5052 and PASM-5052, were 
used for expression screening given in table 1. 
 
Table 1 – Ingredient preparation of the media used. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Further details of medium preparation are given in Studier, 2005. 
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3.2.3 - Small-scale expression 
Expression screening was carried out from 5 mL cultures volumes using 24-well 
culture plates (Qiagen) with aerated plate sheet covers. From a fresh colony, 
overnight LB cultures were diluted 1:50 in the tested medium and incubated at 37°C 
to an OD600 of 0.5 followed by a further 15 hours at 25°C. An IPTG-induction step at 
an OD600 of 0.5 was carried out with 0.4 mM IPTG where specified. With the 
Lemo21(DE3) strain, media were supplemented with 0, 0.1, 0.25, 0.5, 0.75 and 1.0 
mM L-rhamnose before inoculation. 
 
3.2.4 - Flow cytometry analysis 
Membrane protein expression was monitored on a cell population level, from fresh 
small-scale cultures using a FACSCalibur instrument (BD Biosciences) (Wagner et 
al., 2008; Schlegel et al., 2012). Cells were diluted to a final concentration of !106 in 
2 mL of ice-cold 1 x PBS buffer. Diluted cells were incubated on ice for 30 min in the 
dark with 0.2 μM of membrane staining fluorophore FM4-64 (Invitrogen). For data 
analysis, cell gating was based on FM4-64 staining and GFP-fluorescence was 
detected and presented logarithmically using the FlowJo software (Treestar). The 
FACS experiments and data analysis were carried out by Anna Hjelm (University of 
Stockholm). 
 
3.2.5 - Large-scale expression 
Large-scale expression followed the same protocol as small-scale using 1 L baffled 
shaker flasks. With the Lemo21(DE3) strain, autoclaved media were supplemented 
with optimum L-rhamnose concentration. Cells were harvested at 5,000g for 15 
minutes and re-suspended in 50 mL 1 x PBS buffer for storage at -80°C. 
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3.2.6 - Membrane preparation 
From large-scale expression, thawed cells were lysed by a pressure of 25 kpsi (~ 1.7 x 
103 atm) (twice) through a cell disruptor (Constant Systems) at 4°C. Cell debris and 
unbroken cells were removed by centrifugation at 12,000g for 10 min at 4°C. From 
the supernatant, crude membranes were isolated as a pellet by ultracentrifugation at 
140,000g for 2 hours at 4°C. Membrane pellets were resuspended in 15 mL 1 x PBS 
buffer and flash-frozen in liquid nitrogen for storage at -80°C. 
 
3.2.7 - Quantification of membrane protein expression 
From small- and large-scale expression, a 1 mL aliquot of cells were spun down at 
16,000g for 10 min followed by resuspension in 100 µL 1 x PBS buffer. Cell 
suspension was transferred to a 96-well black Nunc plate with GFP fluorescence 
measured as relative fluorescence units (RFUs) using a SpectraMax 340PC384 
Absorbance Microplate Reader (Molecular Devices, CA). GFP emission was 
measured at 512 nm with an excitation wavelength of 488 nm using the Softmax Pro 
software suite (Molecular devices). Fluorescence was converted to mg.L-1 based the 
ratio of 1:1 of membrane protein expressed relative to its GFP tag (Drew et al., 2008). 
 
3.2.8 – Fluorescent-detection size exclusion chromatography analysis 
For each control protein, crude membranes from a 1 L culture (from standard 
conditions) were diluted to 3.5 mg/mL total protein concentration in 1 mL of 
solubilisation buffer; 1 x PBS, 150 mM NaCl and 1% (w/v) low-α DDM (DDMLα) 
(Generon). The total protein concentration of crude membranes was measured by a 
BCA assay (Thermo Scientific) with bovine serum albumin as a protein standard. The 
same dilution factor was applied to crude membranes of the same control protein 
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expressed in the MemStar condition. Membranes were solubilised for 1 hour at 4°C 
and isolated by ultracentrifugation at 140,000g for 1 hour. The detergent 
solubilisation efficiencies were calculated based on RFU readings taken before and 
after ultracentrifugation. From the supernatent, 100 µL of DDM-solubilised GFP-
fusion was loaded onto a Superose 6 column (10/30, GE-healthcare) pre-equilibrated 
with 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.03% DDM at a flow rate of 0.4 
mL/min. On-line GFP fluorescence was measured at each protein fraction (emission 
wavelength of 512 nm and excitation wavelength of 488 nm). GFP fluorescence was 
plotted against retention volume (mL) using GraphPad Prism software (San Diego, 
CA). 
 
3.2.9 - Membrane protein solubilisation and purification 
 
Buffers 
Solubilisation buffer  1 x PBS, 150 mM NaCl and 1% DDMLα 
Wash buffer 1 x PBS, 150 mM NaCl and 0.1% DDMLα, 10 mM 
Imidazole 
Dialysis buffer 20 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.03% DDMLα 
 
Solubilisation 
Crude membranes were diluted in solubilisation buffer to a final protein concentration 
of 3.5 mg/mL. After 1 hour stirring at 4°C, solubilised membranes were isolated by 
ultracentrifugation at 140,000g for 1 hour at 4°C to remove unsolubilised material in 
the pellet. Detergent solubilisation efficiencies were calculated from RFU readings 
taken before and after ultracentrifugation. 
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Purification 
Solubilised membranes were stirred with 1 mL of Ni-NTA slurry (Qiagen) per 1 mg 
GFP pre-equilibrated with wash buffer for 2 hours at 4°C. The slurry was then 
transferred to a glass Econo-Column (BioRad) and washed with 20 column volumes 
(CVs) of wash buffer containing increasing amounts of imidazole: 20, 30, and 40 
mM. The membrane protein-GFP fusion was eluted in 50 mL of wash buffer 
containing 250 mM imidazole. Cleavage of the GFP-His8-tag was followed with the 
addition of equimolar His6-TEV protease (section 3.2.10) during overnight dialysis in 
3 L of dialysis buffer at 4°C. Reverse immobilised metal affinity chromatography 
(IMAC) was performed using a 5 mL Ni-NTA HisTrap HP column (GE-healthcare) 
pre-equilibrated in dialysis buffer to remove the cleaved GFP-His8 fusion tag and 
His6-TEV protease. Flowthrough containing the target protein was concentrated to 
500 µL using 50 kDa MWCO Amicon Ultra-15 centrifugal concentrators (Millipore) 
at 3,000g at 4°C with 10 min intervals to minimise precipitation during concentrating. 
Size exclusion chromatography (SEC) was performed using a Superdex 200 10/30 gel 
filtration column pre-equilibrated in dialysis buffer. The monodisperse protein peak 
was collected and concentrated using 100 kDa molecular weight cut-off concentrators 
(Vivaspin) to 10 mg/mL. Final protein concentrations were measured by a BCA assay 
and purity assessed from 10 µg of protein by SDS-PAGE analysis. Pure protein was 
used for crystallisation or flash-frozen in liquid nitrogen for storage at -80°C. 
 
3.2.10 – Expression and purification of TEV protease 
The plasmid construct of His6-TEV protease was a personal gift from Dr. Simon 
Newstead (University of Oxford), cloned into the pMal-C2 vector and containing an 
N-terminal maltose binding protein tag (MBP) to improve soluble expression yields. 
$)!!
A TEV protease cleavage site is present between the MBP and TEV protease for 
removal of the MBP during expression by self-cleavage. 
 
Buffers 
Cell resuspension buffer 1 x PBS, 300 mM NaCl 
Purification buffer 20 mM Tris-HCl pH 7.5, 300 mM NaCl, 3 mM DTT 
and 20 % glycerol 
Dialysis buffer 20 mM Tris-HCl pH 7.5, 300 mM NaCl, 5 mM DTT 
and 30 % glycerol 
Storage buffer 20 mM Tris-HCl pH 7.5, 300 mM NaCl, 5 mM DTT 
and 50 % glycerol 
 
Transformations and expression was carried out in the E. coli BL21-
CodonPlus(DE3)-RP strain (Agilent Technologies) supplemented with 100 µg/mL 
carbenicillin. From a fresh colony, overnight LB culture was diluted 1:50 in 5 L of 
autoclaved LB prepared using 1 L baffled shaker flasks. Large-scale cultures were 
incubated at 37°C to an OD600 of 0.5-0.6 followed by induction with 0.4 mM IPTG 
and continued incubation for a further 15 hours at 25°C. Cells were harvested at 
5,000g for 15 min and the cell pellet resuspended in 200 mL cell resuspension buffer 
and either stored at -80°C or immediately lysed by a pressure of 25 kpsi (twice) 
through a cell disruptor (Constant systems) at 4°C. Cell debris and unbroken cells 
were removed by centrifugation at 12,000g for 10 min at 4°C, with the supernatent 
extracted and ultracentrifuged at 140,000g for 45 min at 4°C. The supernatent, after 
ultracentrifugation, was isolated from the pellet of crude membranes and 
supplemented with 20 mM imidazole (final concentration) before being loaded onto 
two 5 mL Ni-NTA HisTrap HP columns (GE-healthcare) connected in series to an 
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ÄKTAprime™(GE-healthcare) pre-equilibrated with purification buffer containing 20 
mM imidazole. The supernatent was run at 2 mL. min-1 followed by purification 
buffer containing 50 mM imidazole for 20 CVs or until the monitored UV absorbance 
at 280 nm had decreased to zero. Bound TEV protease protein was eluted in 100 mL 
purification buffer containing 250 mM imidazole and dialysed overnight in 3 L of 
dialysis buffer at 4°C. The dialysed sample was re-loaded onto the Ni-NTA HisTrap 
columns pre-equilibrated with dialysis buffer containing 20 mM imidazole followed 
by 20 CVs of dialysis buffer containing 50 mM imidazole. Elution of the bound TEV 
protease was carried out using 100 mL of dialysis buffer containing 250 mM 
imidazole, which was added to 350-400 mL storage buffer with a final protein 
concentration of 1 mg.mL-1. Purified TEV protease was finally aliquoted as 5 mL 
volumes into 15 mL falcon tubes for storage at -80ºC. 
 
3.2.11 – Fluorescent based CPM thermostability assay 
The thermostability assay was carried out according to the protocol described by 
Stevens and co-workers (Alexandrov et al., 2008). Stocks of CPM (7-diethylamino-3-
(4'-maleimidylphenyl)-4-methylcoumarin) dye (Sigma) dissolved in DMSO to 4 
mg/mL were prepared as 5 µL aliquots and stored at -80°C. 1 µL of 10 mg/mL 
purified protein was added to 150 µL of buffer containing 20 mM Tris-HCl pH 7.5, 
150 mM NaCl and 0.1% LDAO in a 96-well black Nunc plate. A thawed aliquot of 
CPM dye was diluted to 40 µg/mL in a dilution buffer (20 mM Tris-HCl pH 7.5, 150 
mM, 0.03% DDM) followed by 3 µL added quickly to the protein in the dark. The 
plate was covered with a clear cover plate with fluorescence monitored at an emission 
wavelength of 463 nm with excitation of 387 nm on SpectraMax plate reader pre-
incubated at 40°C. Fluorescent readings were measured every 5 minutes for 3 hours 
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with a 15 second shaking interval. The fraction of folded protein at each time point 
was calculated by the quotient of raw fluorescence measured at each time point 
divided by the maximal fluorescence measured. The T1/2 values were calculated from 
a single exponential decay curve plotted using Graphpad Prism software (San Diego, 
CA). 
 
3.2.12 - Crystallisation 
Crystallisation screens used the MemGold™ 96-well conditions from Hampton 
Research (Appendix I) on 96-well sitting drop plates with 200 nL of purified protein 
mixed with 200 nL of reservoir solution. Crystallisation plates were prepared using a 
Mosquito robot (TTP labtech) and stored at 20°C. Crystallisation trials of the control 
protein TehA from Haemophilus influenza were carried out by Hassanul Choudhury 
(Imperial College London). 
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3.3 - Results 
 
3.3.1 – Control membrane proteins 
The objective of this chapter was to develop a generic expression screen to optimise 
membrane protein expression in E. coli in a high-throughput manner for structural 
biology studies. Expression screening was first conducted from a bacterial library of 
10 “control” integral membrane proteins with published crystal structures, of which 
their crystal forms had successfully been reproduced in-house using a GFP-based 
overexpression and purification pipeline (table 2)(Drew et al., 2001, 2005).!
 
Table 2 – List of 10 control membrane proteins 
 
Membrane 
Protein 
 
Function 
 
Species 
 
Reference 
Mhp1 Benzyl-hydantoin  
transporter 
Microbacterium liquefaciens  (Weyand et al., 2008)  
NhaA* Sodium/proton  
antiporter  
Escherichia coli  (Hunte et al., 2005)  
Yiip Zinc  
transporter  
Escherichia coli  (Lu and Fu, 2007)  
EmrD Multidrug  
transporter  
Escherichia coli  (Yin et al., 2006)  
GlpG Intramembrane  
protease  
Escherichia coli  (Wang et al., 2006)  
AsbT Sodium/bile acid  
transporter  
Neisseria meningitidis  (Hu et al., 2011) 
GlpT Glycerol-3-phosphate 
transporter  
Escherichia coli  (Huang et al., 2003)  
AmtB Ammonium  
channel  
Escherichia coli  (Zheng et al., 2004)  
LacY Lactose  
permease  
Escherichia coli  (Abramson et al., 2003)  
TehA Tellurite  
channel  
Haemophilus influenza  (Chen et al., 2010)  
* An NhaA mutant (A109T, Q277G and L296M) was used as it produced higher 
resolution diffracting crystals than the wild type, described in Chapter 4. 
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3.3.2 - Effect of media type 
The type of medium was first tested, as this is the easiest parameter to adjust. 
Membrane protein expression yields in C43(DE3) cells were first monitored in LB 
and a routinely used auto-induction medium ZYM-5052. The expression yields in 
each medium condition were compared by converting the measured GFP relative 
fluorescence units (RFUs) to mg.L-1 and divided by the final OD600 to give the final 
overexpression level normalised to cell density (mg.L-1.OD600-1). To simplify the 
comparisons between the different overexpression conditions, the average 
overexpression levels normalised to cell density is only indicated for each expression 
condition. 
 
The ZYM-5052 auto-induction medium produced a slightly lower average 
overexpression level (2.8 mg.L-1.OD600-1) compared to cells grown in LB (3.0 mg.L-
1.OD600-1) (figure 3.1), indicating that the increased yields reported in auto-induction 
media are most likely due to the increased biomass (Deacon et al., 2008). It is 
understood, however, that recombinant membrane protein expression is typically poor 
if induced late in the E. coli growth phase (Drew et al., 2005). With reference to this, 
expression screening was repeated in the ZYM-5052 medium with a standard IPTG-
induction step at mid-log phase as carried out in the LB medium. In other words, we 
were using the ZYM-5052 as a “non” auto-induction medium. !
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Figure 3.1 – Expression screening in different medias and culture conditions. 
Box-and-whisker plot illustrating the distribution of membrane protein expression 
(mg. L-1) normalised to cell density (OD600) for the 10 control membrane proteins in 
each of the different culture conditions as labelled. The bottom and top of each box 
represents the 25th and 75th percentile with the whisker lines indicating maximum and 
minimum expression levels in each condition with the vertical line representing the 
mean normalised expression level (mg. L-1.OD600-1). The coloured boxes represent the 
culture conditions further tested. 
 
The addition of IPTG-induction in the ZYM-5052 medium further increased average 
overexpression levels from 2.8 mg.L-1.OD600-1 to 3.7 mg.L-1.OD600-1 (figure 3.1). To 
investigate this combination further, another auto-induction medium, PASM-5052, 
was next tested. PASM-5052 auto-induction medium is generally used for 
selenomethionine (SeMet) protein labelling, a commonly used heavy atom derivative 
for crystallographic phasing (Morth et al., 2006), but can still be used as a standard 
medium without selenomethionine (Studier, 2005). By switching from ZYM-5052 to 
PASM-5052 with IPTG induction, overexpression levels increased even further from 
3.7 mg.L-1.OD600-1 to 5.1 mg.L-1.OD600-1 (figure 3.1). So far, just by switching the 
medium, a ~ 1.6 fold higher average overexpression level normalised to cell density 
was obtainable using PASM-5052 with IPTG induction in comparison to LB. For this 
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reason, further expression optimisation was carried out on PASM-5052 with IPTG 
induction. 
 
3.3.3 - Expression optimisation using Lemo21(DE3) 
We next decided to test the Lemo21(DE3) strain in both LB and the PASM-5052 
medium with IPTG induction to see if it could further improve overexpression levels 
compared to the C43(DE3) strain. 
 
In Lemo21(DE3) the average membrane protein overexpression level increased from 
5.1 to 6.9 mg.L-1.OD600-1. As such, a further 35 % improvement was made compared 
to growth in C43(DE3) cells, as shown previously in figure 3.1. Furthermore, the 
presence of selenomethionine in the PASM-5052 medium did not drastically affect 
overexpression levels from Lemo21(DE3) cells (figure 3.2). In LB, however, there is 
no improvement in the use of Lemo21(DE3) compared to C43(DE3). !!!!!!!!!!!!!!!!!
Figure 3.2 – Membrane protein expression yields with selenomethionine 
incorporation. Expression levels from the 10 control proteins using the 
Lemo21(DE3) strain in the PASM 5052 medium with IPTG induction with/without 
selenomethionine incorporation. Expression levels with selenomethionine are given as 
a percentage of the expression levels produced without selenomethionine present. 
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The optimal L-rhamnose concentration varied between the control proteins in both 
media types (figure 3.3). Mhp1 was the only membrane protein to have optimal 
overexpression without the addition of L-rhamnose. Interestingly for each control 
protein, the optimal L-rhamnose concentration with maximal overexpression was the 
same in both media types. After analysing the overexpression data more closely, we 
also found that the expression yields using 0.25 mM L-rhamnose were always at least 
65% of the maximal overexpression level attainable, as shown in figure 3.3 and later 
in figure 3.7. 
 
Using the final combination, the average overexpression levels normalised to cell 
density increased by 230%. That is, from 3.0 mg.L-1. OD600-1 for the standard 
conditions (C43(DE3) cells grown in LB) to 6.9 mg.L-1. OD600-1 for the new optimised 
conditions of Lemo21(DE3) cells grown in PASM-5052 with an IPTG induction step, 
as shown in figure 3.1. For sake of simplicity, it was decided to name this final 
overexpression combination as MemStar. !!
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Figure 3.3 – Optimised expression levels using the Lemo21(DE3) strain. 
Expression levels from the 10-control proteins in the presence of the indicated 
amounts of L-rhamnose using PASM-5052 with IPTG induction. The L-rhamnose 
concentration producing the highest overexpression levels was selected for large-scale 
expression. 
 
 
3.3.4 - Flow cytometry analysis 
To understand how the PASM-5052 auto-induction medium and Lemo21(DE3) strain 
was improving membrane protein expression, we analysed the evolution of MemStar 
by fluorescence-activated cell sorting (FACS) analysis. Membrane protein 
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overexpression levels were monitored by GFP fluorescence and the total cell 
population by the use of a membrane binding fluorescent dye FM4-64. Instead of 
conducting FACS analysis on all 10-control proteins, we focused our efforts on the 
control protein AsbTNM. This control was chosen since its overexpression levels was 
closest to the calculated average overexpression level normalised to cell density 
across all 10-control proteins. 
 
With C43(DE3) cells grown in LB, a large fraction of cells did not express the target 
protein (non-expressing cells) (figure 3.4, red line). By switching to PASM-5052, 
however, this non-expressing cell population reduced (figure 3.4, orange line). By 
including an IPTG induction step, the fraction of cells expressing the control protein 
further increased as well as the amount produced from the expressing cells (figure 3.4, 
brown line). The most straightforward explanation is that by switching to the auto-
induction medium, we have suppressed residual “leaky” expression. That is, since the 
overexpression of membrane proteins is generally “toxic” to cell growth, in LB the 
leaky expression may have been culling viable expressing cells. Interestingly, by 
including IPTG induction to the auto-induction media, we dramatically maximise the 
amount of membrane-integrated expression levels from an increased fraction of 
expressing cells. Although we do not have an explanation for this, it seems that cells 
reaching stationary phase are not as viable for membrane protein production as those 
at mid-log phase (unpublished data). 
 
As expected, Lemo21(DE3) cells grown in PASM-5052 with IPTG induction 
produced the highest overexpression levels from expressing cells as well as a greater 
fraction of cells expressing the target protein (figure 3.4, blue line). The 
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Lemo21(DE3) strain has recently been shown to reduce the amount of inclusion body 
formation (Schlegel et al., 2012). In line with this, another expression screen study 
using the C43(DE3) strain was shown to express 70 out of 99 membrane proteins 
from Mycobacterium tuberculosis in E. coli with >94% of expressed proteins forming 
some degree of insoluble aggregation (Korepanova et al., 2005). Since cytoplasmic 
aggregates can deplete the cell of viable chaperones, such as blockage of the Sec 
translocon machinery, this is one reason why we think Lemo21(DE3) can increase 
membrane protein overexpression yields. With Lemo21(DE3) we can fine-tune the 
optimal strength of the T7 promoter to further maximise the amount of membrane-
integrated expression with a reduction of the adverse effects leading to cell toxicity. !!!!!!!!!!!!!!!!!
 
 
 
 
Figure 3.4 – Flow cytometry analysis of the control protein AsbTNM. 
Overexpression of the AsbTNM was carried out in C43(DE3) cells grown in LB (red), 
PASM-5052 (orange), PASM-5052 with IPTG induction (brown) and Lemo21(DE3) 
cells grown in PASM-5052 with IPTG induction (blue). The coloured culture 
conditions correspond with the box-and-whisker plots in Figure 3.1. (note: AsbTNM 
was selected due to its close membrane protein expression levels (mg.L-1.OD600-1) to 
the mean expression level of the 10-control proteins). FACS experiment and data 
analysis were carried out by Anna Hjelm (University of Stockholm). 
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3.3.5 - FSEC analysis 
To examine the quality of a folded membrane protein from using MemStar, crude 
membranes from the 10-control proteins were isolated from 1 L cultures and 
solubilised in 1% DDM to monitor monodispersity of the detergent-solubilised 
extracts by FSEC analysis. In this case, the use of FSEC has a further practical 
advantage as we can directly compare the quality and amount of DDM-solubilised 
material isolated from the MemStar and standard conditions. All control proteins were 
confirmed to be stable in DDM showing a single, sharp monodisperse trace in both 
expression conditions (figure 3.5).  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 – Quality assessment of overexpressed control proteins by FSEC 
analysis. FSEC traces of DDM-solubilised membranes from the 10 control proteins 
from 1 L cultures grown in standard (red) or MemStar (blue) conditions. 
 
From isolated crude membranes, the average peak heights from using MemStar is 9-
fold higher than from using the standard conditions, which is significantly more than 
the average 2.3-fold increase based only on their normalised overexpression levels 
measured directly from overexpressed cells. Furthermore, the DDM-solubilisation 
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efficiencies were only 40-50% from the MemStar membranes compared to 100% 
from the standard membranes. Even though we could have increased the amount of 
detergent to extract more protein in the crude membranes isolated from MemStar, we 
decided not to, as one of the reasons for developing this overexpression platform in 
the first place was to keep down the financial costs of detergent usage. 
 !
3.3.6 - Purification and crystallisation 
By using membranes isolated from our MemStar protocol, we were able to reproduce 
the crystals from all control proteins in a similar manner to the same protein produced 
previously from standard conditions!(Sonoda et al., 2011). This analysis included the 
bacterial homolog TehA of the plant SLAC1 anion channel, where X-diffraction was 
observed up to 1.2 Å (figure 3.6). As one would expect, the final protein yields using 
MemStar were much higher for all proteins. Taken together, there is no apparent 
compromise in the quality of the protein produced for structural work by MemStar. 
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Figure 3.6 - X-ray diffraction of the control protein TehA. Crystals were grown in 
the MemGold 2.15 condition (refer to Appendix I) from protein expressed using 
MemStar. Crystal screening was carried out on the microfocus beamline I24 at the 
Diamond light source using a Pilatus 6M-F detector. TehA crystals grew in the R3 
spacegroup with the following cell dimensions: a=b= 97 Å, c= 136 Å and α=β= 90° 
and γ= 120°. TehA crystallisation and X-ray crystal screening was carried out by 
Hassanul Choudhury (Imperial College London). 
 
3.3.7 - Large-scale expression screening 
The next step was to test MemStar on a broader range of membrane proteins, in terms 
of their function and size. For a sample set, 24 membrane proteins from a previous 
study were chosen that are known to express from very low (< 1 mg) to high levels  
(> 5 mg) in E. coli using the same pWaldo GFP-fusion vector (Drew et al., 2005). 
MemStar should be useful for large-scale screening, however L-rhamnose titrations 
for every construct becomes impractical. As mentioned previously, we observed that 
with using 0.25 mM L-rhamnose the overexpression levels for the control proteins 
were at least 65% of the maximum expression level obtainable. To investigate this 
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trend more thoroughly, we also screened 11 different mutants of the control 
membrane protein NhaA. Interestingly, the variation in expression levels between 
point mutations of the same protein was as large as that across the 10 different 
proteins (figure 3.7). On a practical level again we observe 0.25 mM rhamnose results 
in at least 65% of the maximum expression level for each tested NhaA mutant. As 
such, we tested expression levels only with this concentration of L-rhamnose in the 
MemStar condition across the additional 24 membrane proteins as well as the 
standard conditions for consistency. 
 ! !! !! !
! !!!!!!!!!
 
Figure 3.7 – Correlation between expression levels and L-rhamnose 
concentration using MemStar. Expression levels are represented as a percentage of 
the highest expression across the indicated L-rhamnose concentrations for the 10 
control proteins (filled circles) and NhaA mutant library (unfilled circles). The dotted 
line on the y axis represents ≥ 65% maximal expression present in 20 out of 21 cases 
at 0.25 mM concentration of L-rhamnose. 
 
Similarly to the first expression screen, the normalised average overexpression level 
from the standard to MemStar condition increased 2-fold, that is, from 2.2 to 3.9 
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mg.L-1.OD600-1 (figure 3.8, part a). After analysing the data in more detail, we 
observed 17 out of the 24 proteins expressing above 12.5 mg.L-1 in the MemStar 
condition compared to only 6 proteins in the standard condition (figure 3.8, part b). 
 
(a) !!!!!!!!!!
!
(b) !!!!!
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8 – Medium-scale analysis of the application of MemStar using an 
established 24-membrane protein-GFP fusion library (a) Box-and-whisker plot 
illustrating the distribution of membrane protein expression (mg.L-1) normalised to 
cell density (OD600) for the 24 control membrane proteins in standard and MemStar 
conditions. The bottom and top of each box represents the 25th and 75th percentile with 
the whisker lines indicating maximum and minimum expression levels in each 
condition with the vertical line representing the mean normalised expression level 
(mg. L-1.OD600-1). (b) Overexpression levels from all membrane proteins in the 
standard and MemStar conditions. Expression levels of at least 2.5 mg.L-1 (lowest 
dotted line) from the standard conditions can be increased to above 12.5 mg.L-1 using 
MemStar (highest dotted line). 
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The average normalised overexpression level across these 17 membrane proteins 
increased slightly more from 2.8 to 5.0 mg.L-1.OD600-1. Interestingly, 6 out of the 7 
membrane proteins expressing less than 12.5 mg.L-1 using MemStar were also the 
poorest expressing proteins in the standard condition showing expression yields less 
than 2.5 mg.L-1. Based on the expression data from this larger test-case of membrane 
proteins, an ad hoc cut-off expression level of ~ 2.5 mg.L-1 can be a suggested 
minimal level of expression required to increase overexpression to above 12.5 mg.L-1 
using MemStar. 
 
Given that the membrane proteins expressing below this ad-hoc level have very 
different functions, this can suggest that MemStar’s failure not to optimise effectively 
their expression levels is not linked to protein-specific toxicity. The lowest expressing 
membrane protein is Atp1, which had its expression increased from 1.2 to 4.2 mg.L-1 
using MemStar. This target is an accessory subunit of the F0F1 ATP synthase and 
documented to poorly translate due to many rare codons (Walker et al., 1984, 
Norholm et al., 2012) and thus its expression levels may be independent of the 
MemStar conditions. 
 
Translation inefficiency was investigated further by codon optimisation from one 
control protein, AraH, which similarly expressed below the ad hoc cut-off level of ~ 
2.5 mg.L-1 by the lab of Professor Daniel Daley (University of Stockholm). Using the 
standard conditions, AraH expression levels increased from 1.1 to more than 2.5 
mg.L-1 after codon optimisation, which was satisfactorily boosted to more than 17 
mg.L-1 using MemStar. 
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3.3.8 – Homologue screening 
 
To investigate further the expression limits of MemStar, we decided to screen 
homologues of two control proteins; EmrD and GlpG (table 3). In this way we can 
minimise the individual membrane protein effects on expression levels; in other 
words homologues with the same membrane protein function are more likely to have 
similar toxicity effects. For EmrD the poorest expressing homologue (Bacillus 
substilis) in standard conditions of 2.4 mg.L-1 was boosted to 35 mg.L-1 using 
MemStar. For homologues of GlpG, however, the three that expressed to levels lower 
than 2.3 mg.L-1 in the standard condition (Shewanella oneidensis, Haemophilus 
influenzae and Pyrococcus horikoshii) could not be optimised to expression levels 
above 12.5 mg.L-1 using MemStar. As a result, this work has shown that the ad hoc 
cut-off expression level of 2.5 mg.L-1 is applicable to homologues of the same protein 
as well as for completely different membrane proteins. 
 
Table 3 – List of selected EmrD and GlpG homologues 
Membrane 
protein Species Standard (mg. L-1) MemStar (mg. L-1) 
  Bacillus cereus 15.5 55.8 
  Pseudomonas putida 11.8 39.6 
  Haemophilus influenzae 7.3 25.5 
EmrD Shewanella oneidensis 5.5 23.4 
  Escherichia coli 4.4 53.0 
  Shigella flexneri 3.9 36.7 
  Bacillus subtilis 2.4 35.4 
  Escherichia coli 17.8 127.3 
  Bacillus subtilis 8.4 37.5 
  Shigella flexneri 5.9 31.9 
GlpG Thermus thermophilus 2.3 34.8 
  Shewanella oneidensis 1.8 8.0 
  Haemophilus influenzae 1.1 5.3 
  Pyrococcus horkoshii 1.2 4.2 
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3.3.9 – Correlation between optimised expression using MemStar and 
thermostability 
One of the original arguments for the development of this system was to improve the 
expression of membrane proteins, which can only be produced to low levels even 
though they may be more stable and therefore more likely to produce well-ordered 
crystals using a small micelle detergent. Our final analysis of the MemStar condition 
was therefore conducted from 9 control proteins, from the first test-case, to compare 
their optimised expression levels with thermostability monitored by their unfolding 
rate in the LDAO detergent; known to produce harsh membrane protein unfolding 
conditions due to its small hydrophobic chain and small charged head group. Based 
on cysteine accessibility, membrane protein unfolding rates were monitored using the 
thiol-specific fluorochrome CPM dye incubated with pure protein in LDAO at 40ºC, 
producing fluorescence upon reacting with free sulfhydryl groups exposed during 
membrane protein unfolding. The calculated LDAO half-life (T1/2) was used to 
compare membrane protein stability with optimised expression. Across all 9 
membrane proteins, the data did not show an obvious linear correlation (R2 = 0.1) 
between optimised expression levels using MemStar and protein stability, as shown 
from figure 3.9. A correlation was more visible with the exclusion of the control 
protein AmtB (R2 = 0.6), however this trend would need to be further verified by 
testing more control proteins. 
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Figure 3.9 – Correlation between membrane protein thermostability and 
optimised expression levels using MemStar. The data across 8 membrane proteins 
(excluding AmtB; shown in red) shows a reasonable correlation (R2 = 0.6) between 
membrane protein stability monitored by the unfolding half-life rates in LDAO at 
40ºC, and the optimised expression levels using MemStar. 
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3.4 - Discussion 
To resolve a high resolution crystal structure of a membrane protein, one important 
parameter is the production of sufficient isolated quantities of monodisperse and 
stable membrane protein. Most often membrane proteins are first tested for 
crystallisation in a protein–detergent micelle. However if expression levels are low 
(<10 mg.L-1), free detergent molecules are likely to be overconcentrated and hinder 
the growth of well-ordered crystals. Ideally, if expression levels could be optimised in 
a high throughput manner, this could justify using small micelle detergents routinely 
in a membrane protein crystallography laboratory and also help hasten the time-
consuming process of crystal optimisation. 
 
Previously in our laboratory, routine protein production of bacterial membrane 
proteins were overexpressed using LB medium and the E. coli expression strain 
C43(DE3); referred to as standard conditions (Miroux and Walker, 1996). By 
combining the PASM-5052 auto-induction medium and the Lemo21(DE3) expression 
strain with IPTG induction, this produced a 2-fold average increase in the normalised 
membrane protein overexpression levels relative to expression levels using the 
standard conditions. This 2-fold increase was established from 10 control membrane 
proteins with solved crystal structures and a library of 24 different bacterial 
membrane proteins known to express from less than 1 mg.L -1 to 5 mg.L -1 in a similar 
setup (Drew et al., 2005). 
 
Expression studies in E. coli have shown auto-induction to produce higher expression 
yields for membrane proteins (Deacon et al., 2008; Gordon et al., 2008). However, in 
some media types, such as Terrific Broth and auto-induction media, the cell biomass 
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increases as well as the expression levels. This was not the case with MemStar. We 
were able to improve the expression level per OD600. Flow cytometry showed that we 
had increased not only the amount of expressed protein produced from an expressing 
cell, but also the population of expressing cells. FSEC analysis confirmed a 
substantial increase in the amount of membrane protein extracted from crude 
membranes, with no apparent loss of quality. The DDM-solubilisation efficiencies 
from MemStar are less than 100% due to their higher total protein concentrations in 
the crude membranes (10-16 mg.mL-1) compared to the standard membranes (4-5 
mg.mL-1). However, given the high expression levels produced from MemStar, one 
can afford to solubilise less protein in order to obtain a higher protein: detergent ratio, 
particularly when using expensive small micelle detergents.  
 
The conditions of MemStar also hold two very practical advantages, making it even 
more suitable for membrane protein crystallography projects. Firstly the PASM-5052 
medium is designed to express selenomethionine-labelled proteins for phase 
estimation in crystallography (Studier, 2005). The expression levels from the 10-
control proteins were virtually independent of selenomethionine incorporation, which 
can provide more flexibility as well as making MemStar, financially, more cost-
effective without the requirement of using a methionine auxotrophic strain. Secondly, 
the Lemo21(DE3) strain can be applied in a high-throughput manner to optimise 
membrane protein expression levels by only altering the concentration of L-rhamnose 
rather than testing a number of different expression strains, which is considered to be 
a more “trial and error” approach! (Wagner et al., 2008). Interestingly, 0.25 mM L-
rhamnose produced at least 65% of maximum expression levels of the optimum 
concentration from 10 different membrane proteins and 11 mutants from the same 
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protein. Consequently, 70% of a further 24 different membrane proteins produced 
expression levels above 12.5 mg.L-1 from using only 0.25 mM L-rhamnose. This 
practical approach can therefore be applied for large-scale high-throughput expression 
screening of multiple constructs or homologues, at the beginning of a structural 
project, followed if necessary by further expression screening using more L-rhamnose 
concentrations. 
 
One unexpected result from screening the 24 control membrane proteins was that 
overall the MemStar condition could not optimise expression levels above 12.5 mg.L-1 
if the control proteins were poorly expressing below 2.5 mg.L-1 from the standard 
conditions. The most likely reason for these membrane proteins still expressing 
poorly is either due to poor translation efficiencies or difficulties in membrane protein 
folding when overexpressed. One control protein, AraH, previously expressed to less 
than 2.5 mg.L-1 in the standard conditions was increased to more than 17 mg.L-1 by 
combining codon optimisation with the use of MemStar. 
 
Based on this data, an ad hoc cut-off expression level of ~ 2.5 mg.L-1 is proposed to 
be the minimum level of expression required to increase expression levels above 12 
mg.L-1 using MemStar. However this cut-off value, itself, should not be taken too 
strictly as an expression benchmark given that one EmrD homologue did show a 
significant increase in expression from 2.4 mg.L-1 to 35 mg.L-1 from using MemStar. 
Nonetheless, out of all 59 membrane proteins tested in this chapter, 83% expressed 
above 12.5 mg.L-1 using MemStar compared to 29% from the previous standard 
conditions. Altogether, this work can justify MemStar to be a potential candidate 
system for high throughput expression for membrane protein production in E. coli. 
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A reasonable correlation is shown between the optimised expresssion levels using 
MemStar from 8 control membrane proteins and their protein stability, which is an 
important factor for obtaining well-ordered crystals (Sonoda et al., 2011). Although, 
one must not ignore the possibility that more stable membrane proteins suitable for 
crystallisation may still show impractically low levels of expression, which require 
the availability of large-scale fermenters to produce enough material compared to the 
more common and easy to use shaker flasks. 
 
MemStar has been confirmed to eliminate this obstacle based on the 3.0 Å crystal 
structure of the sodium: proton antiporter NapA from Thermus thermophilus, which 
was solved after expression screening for more thermostable cysteine mutants for 
phasing purposes. With these much higher expression levels, crystal optimisation took 
less time as routine purifications using a small micelle detergent could be carried out 
from 5 L MemStar cultures. This work is described in Chapter 5. !
'#!!
 
 
 
 
4.0 - 
Structural studies of 
Escherichia coli NhaA 
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4.1 - Introduction 
Even though the first crystal structure of NhaA was solved in an inactive state, it still 
gave us the first insight into the structural arrangement of the antiporter. However, 
since then, an NhaA structure solved in an active state from crystals grown above pH 
6.5 has still not been obtained, which has made it very difficult to understand its 
transport mechanism. Membrane protein instability in a detergent solution at high pH 
is the most likely reason. In this Chapter, our initial approach was to purify and 
crystallise NhaA in a high pH condition where the protein is active. !
James Bowie and co-workers first demonstrated that the likelihood of uncovering a 
stabilising point mutation for a membrane protein was significantly higher than for 
globular proteins (Zhou and Bowie, 2000; Bowie, 2001). However, this observation 
was not taken advantage of until the work of Christopher Tate and colleagues, who 
carried out alanine scanning to design a thermostable mutant of an eukaryotic GPCR 
(turkey β1-adrenergic receptor) that would remain in its functional folded state using 
a small micelle detergent (octyl-thiol-glucoside) for crystallisation (Serrano-Vega et 
al., 2008; Warne et al., 2008). The structure was subsequently solved to 2.9 Å. 
 
The limitation of the above approach is that it requires a high-affinity ligand to 
confirm functionality as part of the screening and thermostabilisation process. Prior to 
the start of my PhD, as part of a small project by a former Master student, NhaA was 
selected to create a more general stabilisation strategy. Stabilising point mutants were 
generated by random mutagenesis and selected based on expression levels (> 1 mg.L-
1) and those that had better than 50% extraction efficiency in 1% β-OG from total 
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membranes, at a concentration of 3 mg.mL-1, after one-hour incubation at 4°C. This 
procedure was carried out because it was apparent that there was a correlation 
between the stability of membrane proteins, as judged by their T1/2 unfolding rates in 
LDAO at 40°C using the CPM-based assay (described in Chapter 3) and their β-OG 
solubilisation efficiency (personal communication with Dr. David Drew). From this 
work, a thermostabilised NhaA mutant was generated that harboured two random 
mutations (Ala109Thr and Gln277His) that produced better crystal growth at high pH 
(above pH 6.5) compared to the wild type. When I joined this project, the first task 
was to see if we could use this thermostabilised NhaA mutant to obtain an active state 
structure. 
 
At the same time, NhaA wild type crystals in the inactive state were also repeated (by 
a former Master student) from purified protein using the GFP-based pipeline. These 
crystals grown at pH 4 were crystallised as a dimer instead of the monomer observed 
in the initial crystal structure (Hunte et al., 2005). A 3.7 Å structural model of the 
NhaA dimer was obtained by molecular replacement using the monomeric structure to 
calculate the electron density map.  
 
The crystal structure of the NhaA dimer was overall very similar to the dimer 
modelled from the cryo-EM maps using the monomeric X-ray structure (Appel et al., 
2009). However, the crystal structure showed the four-stranded β-sheet protruding 
along the membrane plane with a hydrogen bonding network present in the two 
adjacent β-hairpins, compared to the model showing a more curved β-sheet with the 
tips of the β-hairpins pointing towards the periplasm (figure 4.1). During refinement 
of this structure, it was noticed in the core domain that TM 10 showed a misalignment 
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between the electron density and the residue positions. It appeared that the sequence 
of TM 10 extended from residue 287 to 313, rather than from 290 to 316 in the 
published structure (Hunte et al., 2005). Realignment of TM 10 was, therefore, also 
important to confirm as it contains the highly conserved Lys300 residue in the middle 
of the helix, which is critical for ion binding (Kozachkov et al., 2007). For this side 
project, it was decided to introduce a methionine residue on TM 10 for 
selenomethionine protein labelling using MemStar, to use the anomalous signal from 
the selenium atom as a structural parameter to confirm the reassignment of TM 10 in 
the refined NhaA dimeric structure. 
 
 
 
 
 
 
Figure 4.1 – Structure of the NhaA dimer. Cartoon representation of the NhaA 
dimeric model (PDB: 1ZCD, (Appel et al., 2009)) (beige) superposed onto a crystal 
structure of NhaA (green) solved as a dimer. The crystal structure shows the 
orientation of the four-stranded β-sheet on the periplasmic surface more flat compared 
to the model. 
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4.2 - Materials and methods 
 
Detailed descriptions of the protocols used for expression and FSEC analysis have 
been given in Chapter 3. Only further experiments or modifications are described in 
this chapter. 
 
4.2.1 - Site-directed mutagenesis 
The gene cloned in the pWaldo-GFPe plasmid was used as the template for site-
directed mutagenesis. All point mutations were made using the Quikchange Lightning 
Site-Directed Mutagenesis Kit (Agilent Technologies) with forward and reverse 
primers carrying the complementary codon mutation. PCR reactions were carried out 
according to the protocol given with the kit. Point mutations were confirmed by DNA 
sequencing (Source Bioscience) and the resulting DNA sequences analysed using 
EnzymeX. 
 
4.2.2 - β-Octyl-glucoside solubilisation efficiency 
Crude membranes from a 1 L culture were diluted to 3.0 mg/mL total protein 
concentration in 1 mL of solubilisation buffer; 1 x PBS, 150 mM NaCl and 1% (w/v) 
β-OG (Anatrace). The total protein concentration of crude membranes was measured 
by a BCA assay (Thermo Scientific) with bovine serum albumin as a protein standard. 
The membranes were incubated in the solubilisation buffer for 1 hour at 4°C with 
mild agitation, followed by ultracentrifugation at 140,000g at 4°C for 1 hour. 
Detergent solubilisation efficiencies were calculated based on RFU readings taken 
before and after ultracentrifucation. 
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4.2.3 - Heat-FSEC analysis 
The protocol was identical to FSEC analysis with a heat induction step. Detergent-
solubilised membranes (after ultracentrifugation) were incubated at 40°C for 20 min 
followed by centrifugation at 13,000g for 10 min to remove any precipitation formed 
before being loaded into the Superose 6 column. 
 
4.2.4 – NhaA solubilisation and purification 
 
Buffers 
Solubilisation buffer  1 x PBS, 150 mM NaCl and 1% DDMLα 
Wash buffer 1 x PBS, 150 mM NaCl and 0.1% DDMLα, 10 mM 
imidazole 
Dialysis buffer  30 mM MES pH 6.5, 150 mM NaCl, 0.03% DDMLα 
Crystallisation buffer 20 mM sodium citrate pH 4.5, 150 mM NaCl, 0.03% 
high-α DDM (DDMHα) 
 
Crude membranes were diluted in solubilisation buffer to a final protein concentration 
of 6.5 mg/mL. After 1 hour stirring at 4°C, solubilised membranes were isolated by 
ultracentrifugation at 140,000g at 4°C for 1 hour to remove unsolubilised material in 
the pellet. Detergent solubilisation efficiencies were calculated from RFU readings 
taken before and after ultracentrifugation. Solubilised membranes were stirred at 4°C 
with 1 mL of Ni-NTA slurry per 1 mg GFP pre-equilibrated with wash buffer. After 2 
hours the slurry was transferred to a glass Econo-Column (BioRad) and washed with 
20 column volumes (CVs) of wash buffer containing increasing amounts of 
imidazole: 20, 30, 40 and 50 mM. The membrane protein-GFP fusion was eluted in 
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50 mL of wash buffer containing 250 mM imidazole. Cleavage of the GFP-His8-tag 
was followed by addition of equimolar His6-TEV protease during overnight dialysis 
in 3 L of dialysis buffer.  Reverse IMAC was carried out using a 5 mL Ni-NTA 
HisTrap HP column pre-equilibrated in dialysis buffer. NhaA contains 2 histidine 
residues within the first 5 residues of the N-terminus, which resulted in the protein 
binding to the column and not being eluted in the flowthrough. The column was 
washed with 5 CVs of dialysis buffer and then washed with 3 CVs of buffer 
containing 250 mM imidazole with the flowthrough collected containing eluted 
protein, free GFP-His6 tag and His6-TEV protease. The flowthrough was concentrated 
to 500 µL using 100 kDa MWCO Amicon Ultra-15 centrifugal concentrators 
(Millipore) at 3,000g with 10 min intervals to remove any precipitation during 
concentrating. The concentrated sample was diluted 1:60 into crystallisation buffer 
followed by reconcentration to 500 µL with free GFP precipitating out due to the low 
pH. SEC was followed using a Superdex 200 10/30 gel filtration column pre-
equilibrated in crystallisation buffer. The monodisperse protein peak was collected 
and concentrated with 100 kDa molecular weight cut-off concentrators (Vivaspin) to 
10 mg/mL. Final protein concentrations were measured by a BCA assay and purity 
assessed from 10 µg of protein by SDS-PAGE analysis. Pure protein was used for 
crystallisation trials or flash-frozen in liquid nitrogen for storage at -80°C. 
 
4.2.5 - Crystallisation 
Crystallisation trials were set up by the hanging drop vapour method manually using 
24-well VDXm plates (Hampton Research) using the following optimised 
crystallisation conditions previously determined: 
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Low pH (inactive NhaA state) - 0.1 M sodium citrate pH 3.5 (and 4.0),  
0.1 M lithium sulphate and 22 – 36% PEG 400.  
High pH (active NhaA state) -  0.1M MES pH 5.5 – 6.5 or  
     0.1M Tris-HCl pH 7.5,  
     0.1 M lithium sulphate and 22 – 36% PEG 400. 
 
1 µL of purified protein was mixed with 1 µL of mother liquor on a siliconised glass 
cover slide (Hampton Research) and equilibrated over 500 µL of reservoir (mother 
liquor) solution at 20 °C. 
 
4.2.6 - Additive and Detergent screens 
Crystal optimisation was carried out using an additive screen HR2-428 (Hampton 
Research), and detergent screen 1 (Hampton Research) manually on 24-well hanging 
drop plates. A 10-fold dilution of each condition was added to purified protein prior to 
being mixed with reservoir solution. 
 
4.2.7 - Amphiphiles 
Pure protein was incubated for 5 min with 1% Facade-EM (Avanti Polar Lipids) 
before being mixed with reservoir solution. This was also carried out in conjunction 
with the additive and detergent screens. 
 
4.2.8 - Crystal dehydration 
Cover slides containing equilibrated crystal drops were transferred, sequentially 
overnight, to wells containing the same reservoir solution with a 2% increment of 
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PEG 400 up to a final concentration of 34%. Crystals were flash-frozen from different 
PEG concentrations. 
 
4.2.9 - Crystal freezing 
Crystals were mounted in a cryo-loop (Hampton Research) and transferred to 1 µL of 
cryoprotectant solution; crystallisation condition containing 40% PEG 400 with 1% 
crystallisation detergent. After a few seconds, crystals were flash-frozen in liquid 
nitrogen. 
 
4.2.10 - Data collection, processing and structure determination 
X-ray crystal screening and data collection were carried out on synchrotron beamlines 
at Diamond Light Source (Didcot, United Kingdom) and at the ESRF (Grenoble, 
France). The best data set was collected on Diamond beamline I03 from an NhaA 
triple mutant (Ala109Thr, Gln277Gly and Leu296Met), which was designed to 
confirm the proposed repositioning of TM 10 from a refined model of the NhaA wild 
type dimeric structure. 
 
The purpose of growing crystals of this mutant with selenomethionine labelling was 
to locate the position of the selenium atom site from Met296 on TM 10 based on its 
anomalous scattering signal (f’’). This occurs when energy from the emitted X-rays is 
absorbed by electrons in the heavy atom, which changes the phase of the diffracted X-
ray waves and as a result breaks Friedel’s law between pairs of X-ray reflections (hkl 
and –h-k-l), needed for structure determination. The reflections are collected as 
intensities from diffraction images, of which the number of images required for a 
complete data set is dependent on the crystal lattice symmetry, defined by its 
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spacegroup in the asymmetric unit cell. The contribution of anomalous scattering in 
the crystal can be estimated from differences in the measured X-ray intensities 
between these Friedel pairs. This can be used to locate the positions of the selenium 
atoms in the structure. 
 
The maximum anomalous scattering signal from selenium occurs close to its 
absorption edge wavelength, which was determined by a fluorescent scan of the 
crystal, using the program CHOOCH (Evans and Pettifer, 2001) to show the X-ray 
energy (keV) required to produce a peak f’’ signal during data collection. Data 
collection was carried out at a fixed X-ray wavelength of 0.98 Å (12.659 keV). The 
triple mutant crystallised in the same P21 spacegroup with similar cell dimensions 
(shown in table 4 in the results section) to the wild type structure. In this spacegroup, 
at least 180° of diffraction images are required for a complete data set due to the 
anomalous scattering breaking Friedel’s Law. To increase the redundancy of the 
anomalous signal, whilst minimising radiation damage to the crystal during data 
collection, 90° of diffraction images (0.5° per image) were collected from six separate 
crystal wedges across the crystal, showing the same diffraction quality and resolution. 
A total of 450° of data from the first 5 wedges were used in the final data set, which 
were processed and merged together to 3.5 Å using the Xia2 pipeline (Winter, 2010) 
to XDS (Kabsh, 2010) with further processing using the CCP4 suite of programs 
(Collaborative Computational Project Number 4, 1994). 
 
The initial phases from the triple mutant data were estimated by molecular 
replacement (MR) in the program PHASER (McCoy et al., 2007), using the published 
monomeric structure as the search model. In this case, MR was considered the most 
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convenient phasing method by using the atomic positions from the published structure 
to estimate the phases of the triple mutant. An anomalous difference fourier map was 
calculated in COOT (Emsley and Cowtan, 2004) using the estimated phases with the 
differences in the observed structure factor amplitudes between the Friedel pairs. The 
structure factor amplitudes are proportional to the square-root of the intensities, 
collected from the diffraction images. The anomalous difference map showed the 
anomalous peak signals consistent with selenium atoms, of which their positions were 
compared with their corresponding methionine residues from a calculated electron 
density map of the triple mutant. MR was also repeated using one monomer from the 
wild type dimeric structure after TM 10 had been reassigned as the search model. 
Using COOT, an anomalous peak observed at 4.1σ consistent with a selenium atom 
from Met296 was at the same position as Lys300 from the electron density map 
calculated using the published structure for MR. In contrast, the same anomalous peak 
aligned with Leu296 from the electron density map using the wild type structure with 
the reassigned TM 10 for MR. After this leucine residue was substituted with a 
methionine, the selenium peak was exactly on top of the sulphur atom; confirming its 
position in the new wild type structure to be correct. The anomalous peak positions 
from the remaining selenium atoms were also consistent with their corresponding 
methionine residues from both electron density maps, confirming the repositioning of 
only TM 10 in the NhaA structure. 
 
Model building of the NhaA dimer in the program O (Jones and Kjeldgaard, 1997) 
was interspersed with structural refinement using the PHENIX package (Adams, 
2010) to improve the refined model. Since the data from the triple mutant was 
isomorphous with the wild type, the previously refined model of the wild type dimer 
($!!
was used for model building and refinement. During map calculation, B-factor 
sharpening (DeLaBarre and Brunger, 2006) was applied, followed by real space 
electron-density averaging using RAVE (Kleywegt, 2001). 
 
Structural refinement was conducted to minimise the differences between the 
calculated structure factor amplitudes from the refined NhaA model with the observed 
amplitudes from the triple mutant data set. After a refinement cycle, comparisons 
between the calculated and observed amplitudes were made from the Rwork and Rfree 
values, of which the latter uses 5% of reflections not used in refinement to give an 
unbiased estimate of the improvement of the model. Consequently, a decrease in both 
R values would indicate fewer differences between the model and the observed data. 
Due to the 3.5 Å resolution, structural restraints were used to help improve refinement 
of the model by adding more observational data to the model. Non-crystallographic 
symmetry (NCS) restraints were first applied across all four monomers (one monomer 
per NCS restraint group). During the following refinement cycles, secondary structure 
restraints were also applied to add hydrogen bonding distance restraints in the α 
helices. The refined model was also improved with the addition of group B-factor 
restraints to refine the B-factors from multiple atoms per monomer group with also 
TLS (translation/liberation/screw) rigid body restraints present per monomer (Winn et 
al., 2001). Refinement was improved slightly further in the last few cycles using the 
anomalous scattering data from the triple mutant as an experimental phase restraint. In 
the final refinement cycles, the NCS group restraints were only applied across the two 
dimers in the asymmetric unit cell (one dimer per NCS group), to provide less 
restraint between the two monomers to adopt slightly different conformations but still 
preserve the non-crystallographic symmetry between the two dimers. 
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4.3 - Results 
4.3.1 - Improving NhaA stability at high pH 
The provided thermostable NhaA mutant contained two mutations at Ala109Thr 
positioned on TM 3 and Gln277His on the loop proceeding TM 9 (figure 4.2). This 
mutant had previously been shown to produce the best diffraction to 5 Å from crystals 
grown at pH 6.5. To improve the crystal growth quality and resolution, it was decided 
to test more point mutations on residue 277 to see if thermostability could be further 
improved. Using MemStar all tested mutants (given in Table 7, Appendix II) 
expressed to ∼ 130 mg.L-1 compared to ∼ 14 mg.L-1 from the standard conditions, 
previously described in Chapter 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 – An NhaA thermostable mutant. Cartoon representation of NhaA 
showing the position of two thermostabilising point mutations (spheres) generated by 
random mutagenesis (by a former Master student): Ala109Thr (orange) on TM3 and 
Gln277His (turquoise) on loop 9. 
 
Mutation 1!
Ala109Thr!
Mutation 2!
Gln277His!
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Protein stability was monitored by the extraction efficiencies in β-OG from crude 
membranes and LDAO stability using the CPM assay from purified protein. As 
mentioned previously, this procedure was carried out due to a correlation between the 
stability of membrane proteins judged by their LDAO T1/2 unfolding rates at 40°C and 
their solubilisation efficiencies in β-OG (personal communication with Dr. David 
Drew). One NhaA mutant now containing Gln277Gly showed the most promising 
improvement in crystal growth between pH 6.5 – 7.5 with a further small increase in 
protein stability (figure 4.3). However the crystal diffraction did not significantly 
improve further to a resolution better than 4-5 Å. 
 
 
 
 
 
 
 
 
Figure 4.3 –Protein stability of NhaA wild type and thermostable mutants. 
Protein thermostability, shown as a bar chart, was monitored by the LDAO unfolding 
T1/2 at 40°C from DDM-purified protein of the wild type (black) and two 
thermostable mutants (red). A correlation is also observed between their OG 
solubilisation efficiencies, shown in blue, measured from OG-solubilised crude 
membranes and protein thermostability. 
 
 
However, this new thermostable mutant showed a better quality of crystal growth and 
X-ray diffaction at the inactive pH range compared to what had been previously seen 
from the wild type. This was found to be extremely useful for the work in the 
following section. 
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4.3.2 - Structural realignment of helix 10 using selenomethionine labelling 
To confirm the realignment of TM 10 from the refined NhaA dimeric structure was 
correct, selenomethionine-labelling was chosen as a structural parameter. By 
collecting data at the absorption edge wavelength of selenium, the selenomethionine 
residue position could be located based on its anomalous peak signal. Since we were 
most interested in confirming the position of Lys300, which is important in the ion 
binding site, leucine-296 was first chosen for methionine substitution based on its 
close distance to Lys300. At the same time though, two more single methionine 
mutation sites were made at isoleucine- 293 and leucine-302 in case crystals from the 
Leu296Met mutant did not diffract well (figure 4.4) 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 – Position of three methionine substitution sites on helix 10 of NhaA. 
Ribbon representation of helix 10 showing the position of three chosen residues 
(green sticks) point mutated to methionine with their position close to the strictly 
conserved Lys300 residue (turquoise). 
 
 
With the MemStar expression system, expression screening of these mutants was 
efficient, producing yields of 20-40 mg.L-1 which made it very convenient for large-
scale expression from as little as 2 L cultures. Using total membranes, FSEC analysis 
Leu302!
Lys300!
Leu296!
Ile293!
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was carried out from DDM- and LDAO-solubilised membranes, with all three 
mutants showing the same equal and overlapping FSEC traces in these two 
detergents; shown to be a good indicator of membrane protein stability (figure 4.5, 
part a)(Sonoda et al., 2011). Solubilisation and purification was carried out in DDM 
to grow the same crystal form of the wild type dimer. All mutants showed the same 
symmetrical SEC trace with concentrated protein of a pure quality suitable for 
crystallisation (figure 4.5, part b). 
 
(a)      (b) !! !
!!!!!!! ! (c) 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 – Characterisation of an NhaA methionine mutant. All three single 
methionine NhaA mutants showed the same results as shown here from Leu296Met. 
(a) FSEC analysis from detergent solubilised membranes in DDM (black) and LDAO 
(green) that were extracted from crude membranes. (b) SEC analysis from DDM-
purified protein with protein quality confirmed by SDS-PAGE analysis (in inset). (c) 
Crystals grown to full size after 3-4 days at 20°C in 0.1 M sodium citrate pH 3.5, 0.1 
M lithium sulphate and 28% PEG 400 with 1% (w/v) heptyl-thiol-β-D-glucoside and 
1% hexanediol. 
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Crystallisation was carried out using the optimised crystallisation conditions of the 
wild type; 0.1 M sodium citrate pH 3.5 (and 4.0), 0.1 M lithium sulphate and 22 – 
36% PEG 400. The same wild type crystal form grew from all the mutants (figure 4.5, 
part c) with the most promising X-ray diffracting crystals from Leu296Met with a 
resolution of ∼ 4-5 Å. These crystals grew in 32% PEG 400 at pH 3.5 with 1% (w/v) 
heptyl-thiol-β-D-glucoside and 1% hexanediol. However, the resolution could not be 
improved further despite numerous crystallisation trials. Secondly, radiation damage 
was a problem during data collection due to the low crystal symmetry spacegroup 
(P21), meaning that at least 180º-360º of diffraction patterns were needed to get a 
complete data set due to the breakage of Friedel’s Law from the selenium atom. In 
this case we were also more interested in getting an accurate anomalous signal from 
the selenium atom, in which one then wants to collect even more data to get a high 
redundancy. 
 
4.3.3 - Crystal optimisation using a thermostable NhaA mutant 
To improve the efficiency of crystal optimisation of the Leu296Met mutant, this 
mutation was added onto the thermostable NhaA mutant that had grown consistently 
better crystals than the wild type at low pH (section 4.3.1). For clarity this mutant 
with now three point mutations is referred to as the triple mutant. Encouragingly, this 
triple mutant showed a further increase in its β-OG-extraction efficiency and LDAO 
stability (figure 4.6, part a). Protein thermostability was also monitored by heat-FSEC 
analysis from LDAO-solubilised membranes, with the wild type showing a slightly a 
broader trace compared to the other two tested thermostable mutants (figure 4.6, part 
b). Applying a heat step before FSEC analysis has become a more efficient way to 
screen thermostable membrane proteins earlier from isolated crude membranes 
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without the process of protein purification!(Hattori et al., 2012; Leung et al., 2012). 
Using MemStar, expression levels increased significantly to 100 mg.L-1 with 
selenomethionine labelling, which was sufficient to grow 2 L large-scale cultures. 
Protein of a pure quality was concentrated to 10 mg.mL-1 with a final volume of 1 mL, 
which significantly reduced the time taken for crystal optimisation as numerous 
crystallisation plates could be set up after one purification prep (figure 4.6, part c). 
 
 
(a)      (b) 
 
 
 
 
 
 
 
 
 
 
(c)      (d) 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6 – Protein stability and characterisation of an NhaA triple mutant. 
This mutant was derived by adding the Leu296Met mutation onto the previously 
made NhaA thermostable mutant containing two point mutations (Ala109Thr and 
Gln277Gly). (a) The triple mutant (green) shows a further improvement in 
thermostability based on its LDAO unfolding T1/2, shown as a bar chart, than the wild 
type (black) and thermostable mutant before the methionine mutation was added (red) 
and OG solubilisation efficiency, shown in blue. (b) Heat-FSEC analysis involved 
incubation LDAO-solubilised membranes for 20 mins at 40°C before FSEC. 
Coloured traces are the same as part (a). (c) SEC analysis from DDM-purified protein 
with protein quality confirmed by SDS-PAGE analysis (in inset). (d) Crystals grown 
to full size after 3-4 days at 20°C in 0.1 M sodium citrate pH 3.5, 0.1 M lithium 
sulphate and 28% PEG 400 with 1% (w/v) heptyl-thiol-β-D-glucoside, 1% hexanediol 
and 1% Facade-EM. 
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The same crystal form was grown from the triple mutant using the crystallisation 
conditions previously described for the Leu296Met crystals (figure 4.6, part d). From 
this particular prep, the amphiphile detergent Facade-EM (Avanti Polar lipids) was 
also tested to optimise crystal growth. Due to the largest crystals growing in 22% 
PEG 400, crystal dehydration was carried out to minimise the formation of ice 
crystals when freezing the crystals under liquid nitrogen conditions before X-ray 
analysis. 
 
One crystal dehydrated to 32% PEG 400 showed the best diffraction to 3.5 Å with the 
same unit cell dimensions as the wild type (table 4). Unlike the crystals only 
containing the methionine mutation, much more data (>360º) was able to be collected 
from this triple mutant from different sections of the crystal showing uniform 
diffraction and resolution to help maximise the anomalous signal: noise ratio. 
 
4.3.4 - Realignment of helix 10 
The aim of collecting a high redundancy data set was to obtain a convincing 
anomalous peak signal from the selenium atom to confirm if its position aligned with 
residue 296 from the refined NhaA dimeric structure with the proposed realignment 
of TM 10. Molecular replacement was, therefore, carried out by using only the 
monomer as a search model from the refined dimeric structure, before and after the 
realignment of TM 10, as well as the published structure for consistency. The 
resulting electron density maps using the triple mutant data all showed the same 
overall size and shape as the previous wild type dimeric structure with the anomalous 
difference map of the selenium atom aligned with Met296 from TM 10 after 
realignment (figure 4.7). The nine other selenium atoms aligned with the methionine 
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residues from both the wild type monomer and dimeric structures, suggesting no other 
major structural changes in the other 11 helices apart from TM 10. This was further 
verified after structure refinement with the refined 3.5 Å wild type structure showing 
no visible differences in the helix positions, apart from TM 10 (table 4). 
 
Table 4 – Data collection and refinement statistics of the NhaA triple mutant 
 
Crystal Triple-mutant  
Beamline I03 
Detector Pilatus 6M-F 
Wavelength (Å) 0.9793 
Space group P21 
Resolution (Å) 56.5-3.5 (3.54-3.50)a 
Cell dimensions (Å) a=115.8 b=99.4, c=140.2 
α=90º, β= 97º, γ=90º 
Number of measured reflections  313,049 
Number of unique reflections 37,951 
Completeness (%) 94.6 (69.5) 
Redundancy 8.2 (7.2) 
I/σ(I) 22.0 (1.4) 
Rmerge (%) 4.4 (111.4) 
Refinement  
Number of reflections used 34,855 
Number of atoms 11,331 
R-factor (%) 27.2 
R-freeb (%) 30.4 
R.m.s.d. from ideal values  
           Bond lengths (Å) 0.010 
           Bond angles (°) 1.48 
Ramachandran plot outliersc (%) 2.4 
  a Values in parentheses refer to data in the highest resolution shell 
  b Based on 5% of the reflections 
  cFrom Molprobity (Chen et al., 2010) 
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Figure 4.7 – Helix 10 realignment of NhaA. (a) Electron density of TM 10 with the 
2mFo-DFc map shown in blue with the phases estimated from the NhaA wild type 
dimer structure before realignment of TM 10 (contoured at 1.5 σ). The anomalous 
difference map shown in red has been calculated from the SeMet-labelled triple 
mutant (contoured at 3.6σ) showing alignment of the anomalous selenium peak from 
Met296 with Lys300 (left) instead of Leu296. (b) The same electron density maps 
displayed as part (a) but with the phases estimated from the wild type structure with 
the predicted realignment of TM 10 starting from 287 to 313 (compared to 290 to 316 
in published structure) with Leu296 aligned with an anomalous selenium peak. (c) 
Cartoon representation of the the final refined structure of the NhaA triple mutant 
(green) superposed onto the published structure (grey) showing a good overall 
alignment of the position of the helices (excluding TM 10) with anomalous difference 
map (same as part a) showing all methionine residues (green spheres) in the same 
corresponding positions as their anomalous selenium peaks (blue) including Met296 
(cyan sphere) from the refined NhaA structure, which has moved 7 Å lower towards 
the cytoplasm compared to the original position of Leu296 (purple stick) in the 
published structure. Figures were prepared by Dr. Alex Cameron using ccp4mg 
(Potterton et al., 2004). 
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4.3.5 - New observed salt-bridge pair in the ion binding site 
The realignment of TM 10 did not change the arrangement of the core domain 
showing a root mean standard deviation (r.m.s.d.) of 0.9 Å from 173 out of 179 Cα 
atoms between the NhaA dimer and published monomer. However, the position of 
Lys300 is now shown to be 9 Å closer to the ion binding site and within a salt bridge 
distance (2.7 Å) with the putative ion binding residue Asp163 (figure 4.8). We think 
that this Lys300-Asp163 salt bridge pair observed at low pH may be important to the 
transport mechanism, as mutagenesis of Asp163 is known to abolish transport activity 
(Inoue et al., 1995). This is discussed in more detail in Chapters 5 and 6. 
 
 
Figure 4.8 – Position of Lys300 after realignment of helix 10. Cartoon 
representation of the NhaA structure showing only the core domain viewed from the 
periplasmic facing side of the membrane with the published structure (grey) 
superposed onto the new NhaA structure (green). Important charged residues in the 
ion binding site are shown as sticks with D133 (TM 4), D163 and D164 (TM 5) in the 
same positions from both structures apart from K300 (TM 10). The new position of 
K300 in the new structure (labelled in red text) is proposed to form a salt-bridge 
interaction with D163. TM 3 has been omitted for clarity. 
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Structural studies of  
Thermus thermophilus NapA  
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5.1 - Introduction 
 
The work from this Chapter was carried out to see if a more naturally thermostable 
bacterial NhaA homologue could grow a better quality of crystal in an active pH 
condition compared to the thermostabilised NhaA mutant described in the previous 
chapter. 
 
Prior to starting my PhD, NapA from Thermus thermophilus was selected as a 
suitable candidate for crystallisation. This CPA2 bacterial Na+/H+ antiporter was 
confirmed to be stable in a wide range of detergents, including LDAO, from FSEC 
analysis with a higher LDAO unfolding T1/2 compared to NhaA wild type. Although 
the sequence identity between both proteins is less than 15%, the bacteria NapA 
genes, as expected, strictly conserve the same important residues localised in the ion 
binding site of NhaA (previously shown in figure 2.4), with similar mutant 
phenotypes confirming both to function using the same pH-dependent transport 
mechanism (Furrer et al., 2007). Interestingly, NapA from T. thermophilus shows 
21% sequence identity to the human NHA2 isoform in the CPA2 family compared to 
15% with E. coli NhaA (Xiang et al., 2007). Thus, this justified crystallographic 
studies on NapA to complement the structural and biochemical work of NhaA. 
 
Much better X-ray diffraction crystals were obtained from NapA purified in DDM 
compared to the thermostable NhaA mutant, which were grown at pH 9 where the 
protein is most likely to be in an active state. Before joining this project, a 3.5 Å data 
set had previously been collected using SAD from a selenomethionine-labelled 
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crystal. Unfortunately the anomalous signal from the selenium atom was not good 
enough to estimate the phases, which were needed to calculate an electron density 
map of the NapA structure using the electron density equation. Molecular 
replacement was also tried to determine the phases from this data set using the NhaA 
monomeric structure as a search model, however, this approach did not work most 
likely due to the low sequence identity between NapA and NhaA. Crystal 
optimisation was also continued for native NapA crystals to try and collect a data set 
of the same quality as the collected selenomethionine data set, which could both be 
used to estimate the phases by isomorphous replacement. However, NapA crystals 
were often fragile due to the high solvent contents, making them more prone to 
radiation damage and resulting in poor X-ray diffracting resolution. Another problem 
was that DDM-purified NapA protein crystallised in the lowest crystal symmetry 
spacegroup (P1), which meant that when collecting data from a crystal, it had to be 
rotated at least 360º to obtain all the structural information needed from the 
diffraction patterns to solve the structure. Crystal damage during data collection 
therefore became an ongoing problem. 
 
The main task was to improve the NapA data to estimate phases from primarily NapA 
crystals derivatised with a different type of heavy atom (HA) bound ideally on the 
membrane protein surface. In this work we also investigated the use of a small micelle 
detergent to try and further improve crystal quality and X-ray diffracting resolution. 
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5.2 - Materials and methods 
 
Experiment protocols not described in this chapter are previously described in both 
Chapters 3 and 4 with only further experiments or modifications given in this 
Chapter. 
 
5.2.1 – NapA solubilisation and purification 
 
Buffers 
Solubilisation buffer  1 x PBS, 150 mM NaCl and 1% DDMLα 
Wash buffer 1 x PBS, 150 mM NaCl, 10 mM imidazole and  
0.1% DDMLα, 
Detergent exchange 1x PBS, 150 mM NaCl, 250 mM imidazole and  
0.6% buffer NM 
Dialysis buffer  20 mM Tris-HCl pH 7.5, 150 mM NaCl and 0.5% NM 
Crystallisation buffer  20 mM Tris-HCl pH 7.5, 150 mM NaCl and  
0.45% NM 
 
Crude membranes were diluted in solubilisation buffer to a final protein concentration 
of 3.5 mg/mL. After 1 hour stirring at 4°C, solubilised membranes were isolated by 
ultracentrifugation at 140,000g for 1 hour to remove unsolubilised material in the 
pellet. Solubilisation efficiencies were calculated from RFU readings taken before and 
after ultracentrifugation. Solubilised membranes were stirred with 1 mL of Ni-NTA 
slurry per 1 mg GFP pre-equilibrated with wash buffer. After 2 hours the slurry was 
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transferred to a glass Econo-Column (BioRad) and washed with 20 column volumes 
(CVs) of wash buffer containing increasing amounts of imidazole: 20, 30,40 and 50 
mM. The membrane protein-GFP fusion was eluted using 50 mL of detergent 
containing 250 mM imidazole. Cleavage of the GFP-His8-tag was followed by 
addition of equimolar His6-TEV protease during overnight dialysis in 1.5 L of dialysis 
buffer. Reverse IMAC was carried out using a 5 mL Ni-NTA HisTrap HP column 
pre-equilibrated in dialysis buffer with eluted protein collected in the flowthrough. 
Protein was concentrated to 500 µL using 100 kDa MWCO Amicon Ultra-15 
centrifugal concentrators (Millipore) at 3,000g with 10 min intervals to remove any 
precipitation during concentrating. SEC was followed using a Superdex 200 10/30 gel 
filtration column pre-equilibrated in crystallisation buffer. The monodisperse protein 
peak was collected and concentrated with 100 kDa molecular weight cut-off 
concentrators (Vivaspin) to 10 mg/mL. Final protein concentrations were measured 
by a BCA assay and purity assessed from 10 µg of protein by SDS-PAGE analysis. 
Pure protein was used for crystallisation trials or flash-frozen in liquid nitrogen for 
storage at -80°C. 
 
5.2.2 – Mercury derivatisation 
Mercury (Hg) derivatisation was carried out to provide phasing information during 
structure determination. Prior to SEC, 500 µL of concentrated protein was incubated 
on ice with 0.5 to 2.5 mM mercury acetate at different time periods (30 min to 2 
hours).  Free unbound Hg was removed during SEC. Hg-derivatisation was confirmed 
either by the CPM-based unfolding assay or by in-gel fluorescence analysis by mixing 
4 µg of CPM dye (Sigma) to 1 µg of native and Hg-derivatised pure protein of the 
same concentration (10 mg/mL) with the SDS-PAGE gel cassette run in the dark. In-
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gel fluorescence analysis was carried out using an LAS-1000-3000 charged-coupled 
device (CCD) imaging system (Fujiflm) at a fluorescence emission/excitation 
spectrum of 463/387 nm. Absence of a fluorescent band confirmed Hg-derivatisation. 
 
5.2.3 – Size exclusion chromatography light scattering analysis 
Purified NapA protein was loaded onto a Superdex 200 10/300 size exclusion column 
(GE Healthcare) coupled to a Viscotek TDAmax tetra detector array (Malvern) with 
GPCmax solvent pump and integrated auto-sampler, using the OmniSEC software for 
data analysis. The SEC-UV/LS/refractive index (RI) system was equilibrated in 20 
mM Tris-HCl pH 7.5, 150 mM NaCl and 0.03% DDM at a flow rate of 0.3 mL/min. 
Standard gel filtration molecular weight markers were used for calibration and all 
proteins were analysed under the same experimental conditions. Data was collected 
from the RI, Right Angle LS (RALS) and UV280 detectors. The oligomeric state of 
NapA from the NapA-detergent micelle was calculated using methods described 
previously (Slotboom et al., 2008). 
 
5.2.4 – Crystallisation screening and optimisation 
The MemGold™ 96-well crystallisation conditions provided by Hampton Research 
(Appendix I) were used by mixing 200 nL of protein with 200 nL of reservoir solution 
onto 96-well sitting drop plates using a Mosquito robot (TTP labtech). Plates were 
incubated at 4°C and 20°C. 
 
Crystal optimisation trials were set up by the hanging drop vapour method manually 
using 24-well VDXm plates (Hampton Research) mixing 1 µL of purified protein 
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with 1 µL of mother liquor on a siliconised glass cover slide and equilibrated over 
500 µL of equilibrated reservoir solution at 20°C. 
 
The optimised crystallisation conditions for NapA purified in DDM (personal 
communication with Dr. David Drew) were 0.05 M magnesium acetate, 0.05 M 
glycine pH 9, 22- 36% PEG 400. From the initial crystallisation screening plate, the 
optimised crystallisation conditions for NapA purified in NM were 0.001 M zinc 
sulphate, 0.05 M HEPES pH 7.8, 24% PEG 600 (MemGold condition- 2.36; shown in 
Appendix I). 
 
5.2.5 - Crystal dehydration 
Cover slides containing equilibrated crystal drops were transferred, sequentially 
overnight, to wells containing the same reservoir solution with a 2% increment of 
PEG 400 up to a final concentration of 34%. Crystals were flash-frozen from different 
PEG concentrations. Crystal annealing was also carried out on one native crystal of 
the NapA triple mutant on the ID23_2 beamline at the ESRF synchrotron. 
 
5.2.6 - Data processing and structure determination 
 
Data collection 
X-ray crystal screening and data collection were carried out on synchrotron beamlines 
at Diamond Light Source (Didcot, United Kingdom) and at the ESRF (Grenoble, 
France). As our main aim was to estimate the phases for structure determination of 
NapA, data collections of mercury- and selenomethionine- derivatised NapA crystals 
were conducted close to their absorption edge wavelengths, to collect anomalous 
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scattering data from the two different heavy atoms for phase estimation. Two data sets 
were also collected from native NapA crystals for phasing purposes. All data sets 
used to solve the NapA structure were collected from a number of synchrotron visits 
at different beamlines, with their data collection statistics summarised in table 5; 
presented in the results section.  
 
The NapA crystals used during data collection, were grown in three different 
spacegroups. Thus, one can collect fewer reflections for a complete data set if crystal 
symmetry is present. However similarly to the NhaA project, all data sets were 
collected at high redundancy to get as accurate a measure of the observed intensities 
as possible as well as the anomalous scattering from the heavy atoms. The data sets 
collected from the triclinic crystals (P1 spacegroup symmetry) were used to estimate 
the phases. The monoclinic (P21 spacegroup) and orthorhombic (C2221 spacegroup) 
crystals were used for multi-crystal averaging during density modification. 
 
Estimation of Phases 
The first good quality data set was collected from a mercury-derivatised crystal of the 
NapA cysteine double mutant. The data set was processed using the Xia2 pipeline to 
XDS to a resolution of 4 Å, with the same P1 spacegroup and similar cell dimensions 
to the previously collected NapA wild type data set (given in table 5, section 5.3.2). 
The position of the two mercury sites bound to the two mutated cysteine residues in 
the double mutant were located based on their anomalous scattering determined from 
an anomalous difference patterson map using the program RSPS (Knight, 2000). 
Heavy-atom refinement of the two mercury sites was followed using the program 
SHARP (Bricogne et al., 2003), of which initial phases were estimated using the 
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single anomalous dispersion (SAD) function, to calculate an electron density map 
using the electron density equation. The quality of the electron density regions in the 
maps were improved with solvent flattening using SOLOMON (Abrahams and Leslie, 
1996) to reduce the noise signal from the solvent content, representing 71% of the 
asymmetric unit cell. 
 
A native and mercury-derivatised data set collected from crystals of the NapA triple 
mutant were later merged and scaled using SCALEIT in the CCP4 software package 
with the previous double mutant data set as they were all isomorphous; sharing the 
same P1 spacegroup and unit cell dimensions. With the phasing from the double 
mutant, the third mercury atom site from the triple mutant was located from an 
anomalous difference fourier map. In SHARP, heavy atom refinement was repeated to 
refine the positions of all three mercury atom sites using the observed structure factor 
amplitudes of the native and two mercury-derivatised data sets (double and triple 
mutant), where differences would be due to the presence of the heavy atoms. All three 
data sets further improved the phase estimates by multiple isomorphous replacement 
with anomalous scattering (MIRAS) based on the positions of the refined mercury 
atom sites.  An isomorphous data set from a selenomethionine-derivatised crystal of 
the NapA single mutant, processed to 3.5 Å was also merged and scaled together with 
the native and mercury-derivatised data sets. The selenium sites were located from 
anomalous difference fourier maps, which further improved the phase estimates. 
 
After incorporating all these data sets containing two different heavy atom 
derivatives, the updated electron density map after solvent flattening showed an 
improvement compared to the previous maps from only using the double mutant data 
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set. Based on the number of mercury atom sites located in the asymmetric unit cell (8 
from the double mutant and 12 from the triple mutant), four NapA monomers were 
present. 
 
Density modification 
To improve interpretability of the rod-shaped density regions from the helices for 
model building, density modification was the next step. Density modification of the 
electron density map was carried out in DM (Cowtan, 1994) with solvent flattening, 
histogram mapping and non-crystallographic symmetry (NCS) averaging, of which 
the latter was particularly useful in improving the quality of electron density by 
averaging the density across each of the four NCS-related monomers. Four NCS 
operators (one per monomer) were determined in the program O (Jones and 
Kjeldgaard, 1997) based on the mercury atom site positions, which were needed to 
locate the positions of three of the monomers relative to the position of one reference 
monomer. Additionally, an averaging NCS mask was also used to define a set 
electron density volume of each monomer to enclose density averaging between the 
four NCS operators. For this, a mask was made also in O based on the NhaA 
monomer structure. The electron density was becoming more interpretable with 
iterative cycles in DM whilst simultaneously refining the shape of the mask. 
 
Density modification with multi-crystal averaging 
Two more data sets were also collected from two crystals processed in two different 
spacegroups; P21 from a mercury-derivatised double mutant crystal and C2221 from a 
native triple mutant crystal. These two additional data sets were used for multi-crystal 
NCS averaging in DMMULTI (Cowtan, 1994) using the previously determined NCS 
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operators from the triclinic crystals (P1) with new NCS operators determined for the 
monoclinic (P21) and orthorhombic (C2221) crystals, using the most recently refined 
mask of the monomer. The NCS operators for the P21 and C2221 data sets were 
determined by carrying out MR in PHASER using the refined electron density of one 
monomer as a search model to give the orientation and positions of the search model 
to move between the monomer units in the asymmetric unit cell. Similarly, both the 
electron density maps and shape of the mask were improved by iterative cycles of 
multi-crystal averaging. Once no visible improvements could be made to the maps, 
model building was followed. 
 
Model building and refinement 
Model building was carried out in both O and COOT and was facilitated by the 
anomalous peak positions of mercury and selenomethionine sites from anomalous 
difference maps. The electron density of each monomer subunit contained 13 rod-
shaped helices, showing four monomers crystallised as two side by side dimers in the 
same orientation, as if parallel to the membrane plane, which were operated by a 
crystallographic two-fold symmetry axis. The overall size and shape of the density 
from the NapA dimer was similar to the density from the wild type NhaA dimer. 
Model building and structural refinement were interspersed to improve the final 
refined structural model. 
 
Refinement of the model was carried out in PHENIX using the observed structure 
factor amplitudes from the 3.0 Å C2221 data set, whilst monitoring the Rfree and Rwork 
values. The refinement cycles were carried out in a similar manner to the NhaA 
project, with restraints first put on the atomic XYZ coordinates and individual B-
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factors. Secondary structure restraints also showed an improvement to the refined 
model. The final refinement statistics are shown in the results section of Chapter 5. 
Since the data sets used to solve the final NapA structural model were all from 
cysteine mutant crystals, to check that the mutations did not introduce any structural 
effects, MR was carried out using the refined structure as a search model with the 
previously collected selenomethionine data set of the wild type. The electron density 
map produced from the wild type data set was overall very similar to the final density 
map from the refined structure, of which its anomalous difference map also showed 
anomalous peaks from the selenium atom sites in the same positions as their 
corresponding methionine residues. 
 
5.2.7 – Structural analysis with NhaA 
Sequence alignment of NapA and NhaA with their structures solved in this thesis 
were carried out using the PROMALS3D server with manual adjustment in JalView. 
Superpositions were carried out from only the TMs of NapA and NhaA using the 
DaliLite server (Holm and Park, 2000). Lsqman was also used when the core and 
dimer domains of the two structures were superposed separately such that all 
matching C! pairs were less than 3.8 Å apart after the superposition (Kleywegt and 
and Jones, 1994). 
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5.3 - Results 
 
5.3.1 – Mercury derivatisation of NapA 
To help with the phasing of NapA, more focus was chosen to be put on improving the 
X-ray diffraction of HA-derivatised crystals using mercury, which is commonly used 
for phasing by binding to the sulfhydryl group of cysteine residues (Morth et al., 
2006). However, NapA contains no cysteine residues. Using the NhaA structure as a 
model and pair-wise sequence alignment with NapA, two cysteine substitution sites 
were chosen at methionine-20 and valine-166, predicted to be accessible to a free 
mercury atom in a detergent micelle based on their corresponding residue positions in 
NhaA (figure 5.1). To help improve the accuracy of the mercury anomalous signal, a 
double mutant was also made combining Met20Cys and Val166Cys and a triple 
mutant with the same two mutation sites with a third at valine-326. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 – Predicted structural position of three cysteine substitution sites of 
NapA based on NhaA. NhaA structure viewed in the membrane plane showing three 
residues as spheres, of which their corresponding residues in NapA are chosen to be 
mutated to cysteine for mercury-derivatisation. With pair-wise alignment using 
JalView, Leu24 from TM 1 in NhaA aligns with Met20 in NapA (red), Leu173 from 
TM 5 with Val166 (yellow) and Met329 from TM 11a with Val326 (blue). 
NapA – Met20!
(NhaA – Leu24)!
NapA – Val166!
(NhaA – Leu173)!
NapA – Val326!
(NhaA – Met329)!
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The NapA wild type and cysteine mutants expressed to less than 3 mg.L-1 using the 
standard conditions; described in Chapter 3. The MemStar system, however, boosted 
expression levels to ∼ 10-20 mg.L-1, which were much more suitable levels for large-
scale expression and purification. 
 
FSEC analysis was carried out from DDM and LDAO-solubilised extracts from crude 
membranes to screen detergent stability. All mutants were monodisperse in both 
detergents and suitable for purification. Even though the Met20Cys showed a slightly 
broader LDAO trace with a small aggregation peak, it was still considered stable 
enough for purification in the mild DDM detergent (figure 5.2). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 – FSEC analysis of the NapA cysteine mutants. FSEC traces of 
detergent-solubilised membranes in DDM (black) and LDAO (green) from 
Met20Cys, Val166Cys, double (Met20Cys and Val166Cys) and triple (Met20Cys, 
Val166Cys and Val326Cys) mutants. 
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It was decided to first purify and crystallise Met20Cys and Val166Cys in DDM 
with/without mercury derivatisation. Pure protein of a stable quality was obtained 
from both mutants with bound mercury confirmed by both in-gel fluorescence and the 
CPM-based unfolding assay (figure 5.3) as well as by mass spectrometry (St. 
Andrews University). As expected, both mutants grew the wild type crystal form 
using the optimised crystallisation conditions previously determined for the wild type 
at pH 9. 
 
After crystal optimisation trials, the resolution of crystal diffraction from both 
mutants could not be improved higher than 5 Å. Furthermore, the mercury-derivatised 
crystals were more fragile, which made it extremely difficult to collect a complete 
data set with a high redundancy without radiation damage. Crystal optimisation trials 
were also attempted on NapA wild type to obtain a high resolution native data set. 
However, the resolution similarly could not be improved higher than 4 Å due 
primarily to radiation damage during data collection. 
 
The next approach chosen was to test how well the crystal quality and resolution of 
X-ray diffraction of NapA could be improved when purified using a small micelle 
detergent. 
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(a)       (b) 
 
 
(c)       (d) 
 
Figure 5.3 – Characterisation of NapA. All cysteine mutants produced the same 
results as shown here with Met20Cys. (a) SEC profile of purified NapA protein in 
DDM with the purity of 10 mg.L-1 protein used for crystallisation illustrated by the 
Coomassie-stained SDS-PAGE gel (inset). (b) Crystal grown after 3-4 days at 20°C 
using the wild type crystallisation conditions. Two approaches were taken to monitor 
Hg-derivatisation from purified protein using the thiol-specific CPM dye: (c) the 
CPM-based unfolding assay; filled circle, native protein with no Hg added; filled 
triangle, Hg-derivatised NapA protein; open circle, no protein addition (only CPM 
dye) and (d) In-gel fluorescence analysis by mixing 1 µg protein with 4 µg CPM dye 
before loading onto the SDS-PAGE gel. Both methods produced a fluorescent signal 
from only the native NapA protein. 
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5.3.2 - Crystal optimisation using a small micelle detergent 
The detergent nonyl-maltoside (NM) was chosen that only differed from DDM by the 
length of its hydrophobic chain consisting of nine CH2 groups compared to twelve of 
DDM. NapA wild type was first purified to confirm if this protein could be 
crystallised in NM. From 5 L cultures, isolated crude membranes were though 
solubilised in DDM with a detergent exchange into NM beginning from the first 
purification step on the Ni-NTA column. Purification in NM showed the same 
monodisperse SEC peak as in DDM with the same purity of concentrated protein. 
 
Initial crystal hits were made from the MemGold crystallisation screen set up at 20°C, 
with 4 Å X-ray diffraction from crystals grown in 0.001 M zinc sulphate, 0.05 M 
HEPES pH 7.8, 24% PEG 600. This result was encouraging since these first NapA 
crystals already showed an improvement in the resolution before crystal optimisation 
compared to the NapA crystals purified in DDM. While crystal optimisation trials 
were carried out on the wild type, the cysteine mutants were also to be purified in 
NM. 
 
Heat-FSEC analysis was first carried out from crude membranes of the cysteine 
mutants to confirm the mutations did not affect protein stability. As expected, NapA 
wild type showed the same monodispersity traces in LDAO and DDM from FSEC 
and heat-FSEC analysis; therefore was used as a control (figure 5.4). Met20Cys was 
the only mutant showing an aggregation peak in both detergents, therefore was 
excluded from future experiments. 
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Figure 5.4. – Heat-FSEC analysis of NapA wild type and cysteine mutants. DDM- 
(black) and LDAO- (green) solubilised membranes were incubated for 20 min at 40°C 
before FSEC analysis. Only the Met20Cys mutant showed an aggregation peak in 
both detergents suggesting it to be less thermostable compared to the wild type and 
other mutants. 
 
 
Purification of the single Val166Cys, double and triple mutants were carried out in 
NM as the wild type. To help reduce financial detergent costs, 10 L cultures were 
routinely prepared for purification of each mutant, with one half of the purified 
protein sample remaining native and the second half for mercury-derivatisation. The 
same crystal form was grown from all mutants using the same wild type 
crystallisation conditions. During crystal optimisation trials, crystals appeared 
overnight with maximum size reached after 3–4 days (figure 5.5). Interestingly, a 
second new crystal form was also obtained only from the native triple mutant with 
0.025% dichloromethane added as an additive. Selenomethionine-labelled protein of 
Val166Cys was also purified in NM for crystallisation to try and obtain more 
anomalous data from a second HA to improve the phasing information. Crystal 
dehydration was finally carried out before flash-freezing the crystals, primarily to 
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minimise the formation of ice crystals in the cryo-loop but also to test if the quality of 
crystal diffraction could be improved!(Heras and Martin, 2005). 
 
 
(a)      (b) 
 
Figure 5.5 – NapA crystal forms grown from protein purified in NM. (a) Crystal 
form grown from the wild type and all cysteine mutants (native and Hg-derivatised) in 
the wild type crystallisation conditions. (b) A second crystal form grown from only 
protein of the native triple mutant with 0.025% dichloromethane present in the crystal 
drop. 
 
 
The cysteine mutants produced much better X-ray diffraction than the wild type, 
which were mostly triclinic, but very occasionally crystals with different space groups 
were observed (table 5). The best quality data sets were collected from crystals of 
each cysteine mutant which were dehydrated between 26-32% PEG 400. The highest 
resolution data set was collected from the second native crystal form of the triple 
mutant which was orthorhombic. A further improvement in the diffraction spots from 
this crystal was also observed after reannealing on the beamline. 
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Table 5 – Data sets collected from NapA wild type and cysteine mutants 
"#$%&'()*#! C2221! P1! P21!
! Native! Native! Hg! Hg! Se! Se Hg!
! Triple! Triple! Double! Triple! Single! Wild Type! Triple!
Beamline ID23_2 ID23_2 I03 ID23_2 ID23_1 I24 I03 
Detector CCD CCD Pilatus 
6M-F 
CCD CCD Pilatus  
6M-F 
Pilatus 
6M-F 
Wavelength 
(Å) 
0.873 0.873 1.008 0.873 0.979 0.978 1.005 
Resolution 
(Å) 
63.9 – 3.0 
(3.06-2.98)a 
76.6 - 4.0 
(4.09-3.99) 
99.0 - 4.0 
(4.15-4.02) 
92.0 - 4.9 
(5.0-4.87) 
32.0 - 3.5 
(3.62-3.52) 
30 - 3.7 
(3.76-3.70) 
102.0 - 4.4 
(4.56-4.44) 
Cell 
dimensions 
a, b, c (Å) 
 
α, β, γ (°) 
73.8 
82.2 
191.8 
α= 90.0 
β = 90.0 
γ = 90.0 
79.4 
95.5 
105.2 
α= 77.9 
β = 76.0 
γ = 80.9 
78.8 
95.3 
103.8 
α= 77.5 
β = 75.7 
γ = 80.3 
77.2 
95.3 
101.7 
α= 77.1 
β = 77.8 
γ = 79.5 
79.5 
95.1 
104.2 
α= 77.7 
β = 76.3 
γ =  80.8 
a = 79.5 
b = 93.7 
c = 106.0 
α= 77.6 
β = 76.2 
γ = 81.0 
55.0 
204.1 
64.2 
α= 90.0 
β = 98.4 
γ = 90 
Number of 
unique 
reflections 
12265 
(918) 
24327 
(1759) 
22725 
(1653) 
12636 
(925) 
34726 
(2613) 
30528 
(1594) 
8456 
(662) 
Completeness 
(%) 
99.9 
(100) 
98.3 
(97.3) 
97.8 
(95.3) 
98.8 
(98.1) 
97.7 
(97.8) 
99.3 
(99.1) 
96.9 
(96.2) 
Redundancy 
 
11.0 
(9.3) 
4.6 
(4.6) 
7.0 
(6.8) 
8.6 
(8.6) 
15.3 
(15.7) 
3.5 
(3.5) 
3.3 
(3.4) 
I/σ(I) 
 
18.8 
(2.8) 
13.6 
(2.1) 
11.2 
(2.3) 
12.1 
(3.6) 
19.8 
(3.0) 
21.7 
(1.4) 
5.9 
(2.9) 
Rmerge 
 
8.3 
(95.0) 
6.6 
(85.8) 
7.5 
(98.4) 
10.2 
(67.8) 
7.5 
(115.6) 
11.3 
(99.7) 
7.8 
(98.2) 
Phasing 
powerb 
isomorphous 
anomalous 
   
 
0.59 
0.75 
 
 
0.63 
0.76 
 
 
2.29 
2.11 
  
 
a Values in parentheses refer to data in the highest resolution shell 
b Calculated to 3 Å; Phasing power = rms (|FH|/|FPH - |FP +FH||) 
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5.3.3 - Structure determination of NapA 
As shown from table 5, more data sets were from the triclinic NapA crystals, which 
were native, mercury and selenomethionine-derivatised. These were first chosen to 
estimate the phases using MIRAS. Due to the timing of when these data sets were 
collected, the mercury-derivatised double mutant was first used to estimate the phases 
based on its anomalous signal from the two mercury atoms. Four NapA monomers 
were predicted in the asymmetric unit cell where 8 mercury atom sites were located in 
SHARP. A NapA dimer was later confirmed from the triple (both native and Hg-
derivatised) and single (selenomethionine-derivatised) mutants, which were 
incorporated in SHARP to further improve the phases by both anomalous scattering 
and isomorphous replacement. 
 
Due to a 71% solvent content in the unit cell calculated by the Matthews coefficient in 
the CCP4 software package, solvent flattening was first used to improve the initial 
electron density maps in SOLOMON. Density modification was then applied by 
firstly NCS averaging in DM using the four NapA monomeric molecules as operators, 
based on the HA positions using an initial mask made by overlaying the NhaA 
monomer onto the solvent flattened electron density maps using O. Both the electron 
density maps and the shape of the mask were improved during cycle rounds of density 
modification still only using the triclinic data of the cysteine mutants. Once the 
electron density within the refined mask could not be improved further, the maps 
were used as a search model for MR against the mercury-derivatised P21 data set and 
the native C2221 data set, to improve the quality and particularly resolution of the 
maps given the latter data set was collected at the highest resolution of 3.0 Å. Further 
density modification cycles were repeated using DMMULTI to carry out multi-crystal 
**&!!
NCS averaging using the data sets from all the cysteine mutants with operators 
calculated from the refined mask across the three different spacegroups (P1, P21 and 
C2221). The resolution quality of the final refined electron density maps were good 
enough to see two NapA monomers crystallised as a side by side dimer in the same 
orientation parallel to the membrane plane, which are operated by a crystallographic 
two-fold symmetry axis. 
 
Model building of the NapA monomeric structure into the electron density map was 
helped from the anomalous difference maps of the 3 mercury and 5 selenium atom 
sites in the monomer. To confirm the structural model agreed with the observed 
structure factors, the 3.0 Å native C2221 data set was used during structural 
refinement (table 6). 
 
Table 6: Refinement statistics of NapA 
Spacegroup C2221 
Number of reflections used 
(non-anomalous) 
22,911 
Number of atoms 2,824 
R-factor (%) 22.3 
R-freea (%) 24.8 
R.m.s.d. from ideal values  
           Bond lengths (Å) 0.008 
           Bond angles (°) 1.151 
Ramachandran plot outliersb (%) 0.8 
a Based on 5% of the reflections 
b From Molprobity (Chen et al., 2010) 
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As a final confirmation that the final refined NapA structure did represent a 
physiological conformation in a pH-activated state, the previously collected 3.5 Å 
wild type data set collected from selenomethionine crystals grown at pH 9 was 
molecular replaced with the NapA model. At a resolution of 3.7 Å, we could see no 
clear structural differences between the positions of the selenium peaks in the 
anomalous difference maps from the wild type and the methionine positions from the 
refined NapA structure. 
 
5.3.4 - Outward-facing state of NapA 
The size and shape of the NapA dimer is similar to the solved structure of the NhaA 
dimer. To confirm this state was physiological in NapA, SEC-LS analysis was carried 
out from purified protein of the wild type and triple mutant to calculate the protein 
molecular weight in a detergent micelle (figure 5.6). From the wild type and triple 
mutant, the molecular weight was calculated to be 80 kDa, confirming the presence of 
a NapA dimer. 
 
 
 
 
 
 
 
 
Figure 5.6 – SEC-LS analysis of NapA wild type. The molecular weight 
corresponding to the NapA-detergent complex (red line) and NapA only (blue line) is 
as shown (the predicted Mw of NapA is 40.8 kDa) and the purity of the protein used 
for analysis is illustrated by the Coomassie-stained SDS-gel (inset). The triple NapA 
mutant showed the same result as the wild type. 
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The crystal structure shows two NapA monomers positioned side by side with a 
similar arrangement of the helices compared to the NhaA dimer. Structure based 
alignment shows the NapA monomer to have an extra helix at the N-terminus, which 
gives the membrane protein an NOUT - CIN topology. To facilitate structural 
comparisons between the 13 helices of NapA with the 12 from NhaA, this extra helix 
from NapA is referred to as TM -1 (figure 5.7). The structure of the NapA monomer 
shows two pseudosymmetry-related inverted repeats formed by TMs −1 to 5 and TMs 
7 to 12, which intertwine to form a separate core domain and a dimer (interface) 
domain linked together by TM 6 (figure 5.8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7 – Structure based alignment of NapA and NhaA. The coloured helices 
are depicted as coloured filled boxes from red at the N-terminus to blue at the C-
terminus as in Figure 5.8. Aspartate residues, D156/157 (NapA) and D163/164 
(NhaA), likely to coordinate a sodium ion are labelled with a red square. Ionisable 
residues, E333/K305 (NapA) corresponding to D133/K300 (NhaA) are labelled with a 
black square. Sequence alignment was carried out using the PROMALS3D server 
with the NhaA and NapA structures and manual adjustment in JalView. Sequences 
are displayed in ClustalW format. 
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(a) 
 
 
(b) 
 
 
 
 
 
 
 
 
 
Figure 5.8 – NapA topology and structure. (a) From left to right, two inverted 
topology repeat units of TMs -1 to 5 (blue) and TMs 7 to 12 (red) are related by a 
pseudo two-fold axis of symmetry shown by the first repeat overlayed on the second 
after being rotated 90° perpendicular to the membrane. (b) Cartoon representation of 
the NapA structure as viewed in the plane of the membrane depicted in grey. 
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The dimer domains of the two monomers show a buried extensive surface area of 
1800 Å2 with tight hydrophobic helix-helix interactions shown mainly between TM 
"1 from one monomer and TM 7 from the other monomer (figure 5.9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9 – Structure of the NapA dimer. Cartoon representation of the NapA 
dimeric structure viewed from the extracellular side with TMs from one monomer 
labelled black and the other red. The TMs of the dimerisation domains are coloured in 
pale orange (TMs -1, 1, 2, 7, 8 and 9) and the core ion-translocation domains in sky 
blue (TMs 3, 4a-4b, 5, 10, 11a-11b and 12), connected together by TM6 shown in 
grey. 
 
 
5.3.5 - The inward-facing state of NhaA state and outward-facing state of NapA 
Structural comparisons were first made between the inward-facing state of NhaA and 
the outward-facing state of NapA based on their internal asymmetry of the inverted 
topology repeats. Even though the repeats from both proteins are overall structurally 
arranged in a similar manner, NapA contains two 6 TM inverted repeats linked 
together by TM 6 compared to the two 5 TM inverted repeats in NhaA linked together 
by both TM 6 and 7 (figure 5.10). This is due to the extra TM -1 from the first repeat 
in NapA, which is pseudosymmetry-related to TM 7 on the second. To facilitate 
Dimer 
Core Core 
!1 
1 
2 3 
4a 
5 
6 
7 
8 
9 
10 
12 
11a 4b 
11b 
!1 
1 
2 3 
4a 
5 
6 
7 
8 
9 
10 
11a 
12 
4b 
11b 
*"*!!
structural comparisons between the two structures, TM 6 was excluded from both 
with also the removal of TM -1 from NapA and the interfacial TM with the 
preceeding β-hairpin from NhaA. 
 
(a) 
 
 
 
 
 
 
 
 
 
 
 
 
(b) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.10 – Structural comparisons of NapA with NhaA. (a) Outward-facing 
NapA structure (left) and inward-facing NhaA structure (right) as viewed from the 
extracellular side with the removal of the β-hairpin domain located between TMs 1 
and 2 from NhaA to facilitate visual comparison. The core and dimer domain 
boundaries are represented by a grey line. The NapA structure shows an open 
extracellular-facing cavity between the two domains, illustrated as an oval black 
circle. (b) Superposing the helices of the core and dimer domains of NhaA (grey) with 
the same domains of NapA (blue for the Core domain and orange for the dimer 
domain) together (left) and separately (right). TMs -1 and 6 have been omitted for 
clarity. 
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The r.m.s.d. value was 4.7 Å for 215 out of 247 pairs of Cα atoms from both 
structures when the core and dimer domains were superposed together (figure 5.10, 
part a). However this value decreased when the core and dimer domains were 
superposed separately with an r.m.s.d. of 1.8 Å for 134 out of 148!pairs of Cα atoms 
from the TMs in the core domains and 1.9 Å for 62 out of 88 pairs of Cα atoms from 
the TMs in the dimer domains (Figure 5.10, part b). This suggests that the whole 
movement of the core domain relative to the dimer domain may promote alternate 
access between the inward and outward-facing states. 
 
On the cytoplasmic side of NapA, interactions between TMs 3,4 and 5 from the core 
domain and TMs 2 from the dimer domain close the cytoplasmic-facing cavity, which 
opens an outward-facing periplasmic cavity lined with negatively charged glutamic 
acid residues. At the bottom of the outward-facing funnel-like cavity is the location of 
the two ion binding aspartate residues Asp156 and Asp157, which align with the 
corresponding aspartate residues in NhaA also in the same location at the bottom of 
the inward-facing cavity (figure 5.11 and figure 2.4). In the inward-facing state of 
NhaA, both aspartate residues point towards the core domain compared to the 
outward-facing state of NapA, which shows Asp156 pointing towards the dimer 
domain with its side chain positioned at the base of the outward facing cavity (figure 
5.11). Interestingly, the salt bridge pair previously seen between Asp164 and Lys300 
from the NhaA structure after realignment of TM 10 (described in Chapter 4) is also 
observed in the NapA structure between the equivalent Asp157 and Lys305 from TM 
10. 
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Figure 5.11 – Structure comparison of important residues in the ion binding site 
between NapA and NhaA. Cartoon representation of NapA (coloured as in Figure 
5.8) and NhaA (grey) viewed from the extracellular side of the membrane with the 
residues understood to be involved in ion-translocation shown as sticks. The 
corresponding positions of the charged neutralising dipole residues (E333/D133, 
K305/K300) and the ion-binding aspartate (D156/D163) are the same apart from the 
position of the ion-binding aspartate (D157/D164), with D157 in NapA pointing 
towards the base of the open extracellular cavity, illustrated as a black oval circle. A 
sodium ion is proposed to be bound to the solvent-exposed D157 residue for release 
into the periplasm. A salt-bridge interaction is also suggested to be present between 
K305/K300 and D156/D163 in the inward and outward-facing states. 
 
The Lys305 residue from TM 10 in NapA is equivalent to Lys300 in NhaA (figure 
5.7), which both have shown to abolish transport activity when the positive charge at 
this position is removed (Furrer et al., 2007; Maes et al., 2012). This new position of 
the lysine residue from both structures is also likely to be involved in neutralising the 
negative dipoles from the opposing C-termini. However, the aspartate residue 
(Asp133) of NhaA positioned to neutralise the positive dipoles of the opposing N-
termini is not conserved in NapA based on its structural alignment to Ser127 (figure 
E333/D133!
K305/K300!D164!
D157!
D156/D163!
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5.7). Instead from the structure, we can see the side-chain of Glu333 from TM 11b 
taking a similar position to the carboxylate of Asp133 in NhaA, which may be an 
alternative charge-compensating residue (figure 5.11). Alanine substitution of both 
residues have shown the same significant increase in the sodium binding affinity 
(Noumi et al., 1997), implying that these two pseudosymmery-related residues may 
also play a similar role in the ion binding site as well as not being the only negatively 
charged residue involved in charge compensation. 
*"%!!
 
 
 
 
6.0 - 
Final Discussion 
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Na+/H+ antiporters are located on the plasma membrane in all living cells and play a 
vital role in cellular sodium and pH homeostasis (Padan, 2008). Since 2005, the 
inward-facing structure of the well-characterised E. coli NhaA has been the only 
representative crystal structure of a Na+/H+ antiporter. This was crystallised at low pH 
where the protein is inactive (Hunte et al., 2005). With the very fast transport rate of 
NhaA, the first proposal of the transport mechanism was suggested to involve local 
rearrangements of the finely electrostatically balanced discontinuous helices (TMs 4a-
b and 11a-b) in the core domain (Padan, 2008). 
 
However, in the last ten years a number of bacterial crystal structures from different 
secondary transporter families have been determined at high resolution, revealing the 
presence of topology repeats to be a common structural theme (Boudker and Verdon, 
2010). Sodium-coupled transporters in the LeuT and GltPh family folds are shown to 
contain inverted structural repeats that intertwine to form two domains as well as 
discontinuous helices important for ion binding, similar to NhaA (Yernool et al., 
2004; Yamashita et al., 2005; Screpanti and Hunte, 2007). The structure of the Na+-
coupled bile acid symporter AsbTNM has also been shown to have the NhaA fold, 
which first suggested it to be conserved across other secondary transporters (Hu et al., 
2011). Extensive structural comparisons between multiple structures from the same or 
different secondary transporters of the same structural fold have overall given a 
general model of secondary transport involving a two-domain rocking bundle 
movement around a central substrate binding site (Forrest et al., 2011). Consequently 
we cannot rule out the presence of more global domain movements taking place in the 
Na+/H+ antiporter mechanism. 
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The initial goal of this thesis was to try and solve a crystal structure of NhaA in an 
active conformational state, preferably in an outward-facing state to compare with the 
inward-facing NhaA structure. Due to the reduced NhaA stability in a detergent 
solution above pH 6.5 where the protein is active, more progress was made in 
growing crystals at pH 7.8 and 9 from the NhaA homologue, NapA from T. 
thermophilus. Crystallisation studies of NapA were justified to complement the 
structural and extensive functional work of NhaA, since it also strictly conserved 
residues important for transport with the same electrogenic antiport mechanism as 
NhaA (Furrer et al., 2007). Structural progress was significantly made with NapA 
purified in a small micelle detergent, which could not have been a feasible option 
without the use of the MemStar optimised expression system. 
 
The main purpose for developing the MemStar system was to reduce the number of 
membrane proteins being filtered out during the first stages of expression screening, 
which may in fact be more stable and therefore more likely to grow crystals using a 
small micelle detergent. Consequently the use of MemStar helped to obtain two 
crystal structures; an inward-facing state of the NhaA physiological dimer solved at 
pH 3.5 and a new outward-facing state of the NapA dimer solved at pH 7.8. 
 
Bacterial and mammalian Na+/H+ antiporters have been shown to purify as dimers, 
suggesting this oligomeric state to be conserved in the SLC9 family (Williams, 2000; 
Hisamitsu et al., 2006; Rimon et al., 2007). The dimer interface region of NhaA is 
more localised compared to NapA, primarily consisting of the four-stranded β-sheet 
on the periplasmic side rather than the tight hydrophobic packing between helices in 
the inner dimer domains seen in NapA. As yet we do not know the importance of the 
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interactions between TM -1 and TM 7 in NapA for maintaining dimerisation and 
transport activity. Recently, a 7 Å cryo-EM structure of the CPA1 bacterial Na+/H+ 
antiporter, NhaP1 from Methanococcus jannaschii, was solved also containing 13 TM 
helices with two 6 TM topology inverted repeat units forming a dimer and core 
domain similar to NapA (Goswami et al., 2011). Deletion of the TM -1 of NhaP1 
abolished transport activity but did not affect dimerisation, suggesting this helix in 
both proteins to possibly have a direct/indirect role in the transport mechanism 
(Goswami et al., 2011). Interestingly, a new NHE1 topology model has recently been 
proposed based on the observation of 13 helices present in the NhaP1 structure (Lee 
et al., 2012). 
 
The physiological reason for a dimeric state is unclear, although one can suggest that 
a dimer would form a more rigid body and may therefore be important for protein 
stability in the membrane. The NhaA transport activity is not dependent on 
dimerisation although removal of the β-sheet motif is shown to reduce 
complementation growth under extreme salt stress conditions in addition to protein 
stability (Rimon et al., 2007; Herz et al., 2009). The human NHE1 exists as a dimer 
with the two monomers proposed to allosterically regulate each other (Moncoq et al., 
2008). Indeed allosteric regulation of NhaP1 antiport activity has also been recently 
proposed through the action of the additional TM -1 (Goswami et al., 2011). In NapA, 
the beginning of TM -1 points closely towards the outward-facing cavity of its 
neighbouring monomer, therefore such a role of TM -1 involved transport regulation 
cannot be ruled out. 
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The NapA structure is similar to NhaA, which is characterised by the antiparallel 
discontinuous helices, TMs 4a-b and TMs 11a-11b that cross over each other. At the 
base of the outward and inward-facing cavities of the NapA and NhaA structures, 
respectively, is the location of the two strictly conserved aspartate residues likely to 
coordinate a sodium ion based on their position, conservation with mammalian 
Na+/H+ antiporters (Brett et al., 2005), phenotypes of mutants (Kuwabara et al., 2004; 
Padan, 2008), isothermal titration calorimetry (ITC) experiments (Maes et al., 2012) 
and MD simulations (Arkin et al., 2007). Mutation of either residue to an alanine or 
asparagine in NapA completely abolishes transport activity (Furrer et al., 2007). In 
the inward-facing NhaA structure, both Asp163 and Asp164 point towards the centre 
of the core domain. In the outward-facing NapA structure, Asp156 (equivalent to 
Asp163 in NhaA) is similarly orientated towards the centre of the core domain but 
Asp157 (equivalent to Asp164 in NhaA) points more towards the dimer domain, with 
its side chain carboxylate group exposed at the base of the outward-facing periplasmic 
cavity. Given that the NapA crystals were grown at pH 7.8 where the protein is active, 
we predict from our structure and the pKa of aspartic acid that Asp157 is likely to be 
deprotonated. 
 
It was recently shown using solid-state membrane electrophysiology that the transport 
activity profile of NhaA fits a simple H+ vs Na+ kinetic binding model to a single 
common site and that they work equally well in either direction (Mager et al., 2011). 
In other words, the protons and sodium ions compete for binding to the aspartate 
residues. In the NapA and NhaA structures, the location of Asp157/Asp164 
(NapA/NhaA) is shown to be better suited for ion binding. MD simulations of NapA 
have also found that Asp157 can rapidly bind sodium. Looking at this in a broader 
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perspective, Asp157/Asp164 is strictly conserved in all Na+/H+ antiporters from 
bacteria to man in the CPA superfamily as well as in bacterial, yeast and plant K+/H+ 
antiporters from the CPA2 family (Wiebe et al., 2001; Aranda-Sicilia et al., 2012). 
Mechanically, one can consider a simple situation where Na+ and H+ ions compete for 
binding to Asp157/Asp164 that becomes solvent exposed when alternating between 
the outward to inward-facing states. However, how can this explain electrogenic 
exchange from CPA2 Na+/H+ antiporters? 
 
Interestingly, a salt-bridge is observed in both structures between the neighbouring 
aspartate, Asp156 of NapA and Asp163 of NhaA, to the strictly conserved lysine 
residue on TM 10 (Lys305/Lys300 in NapA/NhaA). Lysine residues located in the ion 
binding site have been implicated as proton acceptors in other proton-coupled 
transport mechanisms, such as in the Na+/H+ antiporter-like Nuo subunits of the 
respiratory complex I (Efremov and Sazanov, 2011) and the H+-coupled transporter 
ApcT (Shaffer et al., 2009). Structures of sodium-coupled symporters such as LeuT 
(Yamashita et al., 2005), Mhp1 (Weyand et al., 2008), vSGLT (Faham et al., 2008) 
and BetP (Ressl et al., 2009) also show a co-transported sodium ion in the ion binding 
site at the same position as the proton-accepting lysine residue in the ApcT transporter 
(Shaffer et al., 2009). The same analysis of NhaA with the repositioned Lys300 and 
NapA has similarly shown its amine group in the same position as the co-transported 
sodium ion in the structural homologue AsbTNM (figure 6.1)(Hu et al., 2011). 
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Figure 6.1 – Structural comparison of the core domains of NapA, NhaA and 
AsbTNM. Cartoon representation of TMs 4a-b, 10 and 11a-b of NapA/NhaA 
superposed on TMs 4,8 and 9 of AsbTNM (PDB: 3ZUX; (Hu et al., 2011)) respectively 
and are coloured grey. The sodium Na2 site of AsbTNM is depicted as a purple sphere 
with K305 from NapA and K300 from NhaA (after realignment of TM 10) shown as a 
stick model in a similar position. 
 
 
Given that the active NapA structure was solved at pH 7.8, the lysine residue is more 
likely to be protonated than the aspartate residue based on its higher pKa value. 
However, their pKa values may be reduced by their local environment in the ion 
binding site, causing the aspartate to possibly become deprotonated and consequently 
interact with the protonated lysine residue. With the new NhaA structure also showing 
this salt bridge pair, it is possible that this polar interaction between these two strictly 
conserved residues may be an important component of the transport mechanism, 
which offers a new reason why transport activity is lost when either the carboxylate or 
amine group is mutated (Inoue et al., 1995; Furrer et al., 2007). A recent NhaA study 
has also shown an increase in the pH to activate transport when Lys300 is replaced 
with arginine, implying that the strength of the observed salt-bridge may also affect 
activation of the transport mechanism (Maes et al., 2012). 
4a!
11b!
4b!
11a!
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2!
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From these two structures it appears that this salt-bridge between the lysine and 
aspartate residue is central to the transport mechanism. In collaboration with Dr. 
Oliver Beckstein, during MD simulations of NhaA and NapA the presence of the salt-
bridge was only maintained in the absence of sodium. With NhaA, sodium binding to 
Asp164 eventually caused the salt-bridge to be broken with some simulations 
showing Asp163 coordinating a sodium ion after breakage of the salt-bridge. 
 
Based on the NapA structure and the MD simulations, we suggest that in the inward-
facing state the protonated Asp157/164 residue may first lose a proton (at a higher pH 
of the cytoplasm) to bind to a Na+ ion (figure 6.2). This will subsequently cause the 
Asp156/163 – Lys305/300 salt bridge to break, with the second aspartate also 
coordinating the sodium ion and deprotonation of the lysine residue to release the 
second proton into the cytoplasm. Although Asp133 in NhaA and Glu333 in NapA 
are not essential for transport activity, these residues could also be protonated or 
deprotonated and therefore be involved in sodium coordination when switching from 
the inward to outward-facing state. 
 
Once this salt-bridge is broken, the inward-facing state will switch conformation to 
expose the sodium ion to the periplasm in the outward-facing state for its release in 
the large water-filled cavity. Based on the NapA structure, we propose that after the 
sodium ion is released, Asp156/163 may possibly first accept a proton but is 
immediately taken up by Lys305/Lys300 for reprotonation and consequently reform 
the salt-bridge. Protonation of the Asp157/164 residue may then trigger the outward 
facing state to switch back to the inward-facing state. 
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Figure 6.2 – Schematic model of the NapA transport cycle in the ion binding site. 
From the inward-facing state, D157 will deprotonate when intracellular pH is above 
6.5 and coordinate a sodium ion (magenta sphere) that has entered the ion binding 
site, causing the D156-K305 salt-bridge to break. The subsequent reorientation of 
D156 to coordinate the sodium ion and deprotonation of K305 may then trigger 
conformational changes to switch from the inward-facing to outward-facing state. 
Based on the NapA structure, it is proposed that after sodium ion release into the 
periplasm, the D156-K305 salt-bridge is reformed with protonation of D157 to switch 
back to the inward-facing state (NhaA structure).  
 
 
Conformational changes during Na+/H+ antiport were previously proposed to involve 
local rearrangements of the finely electrostatically balanced discontinuous helices in 
the core domain (Hunte et al., 2005; Padan, 2008). However, we have seen major 
structural differences in the position of the core domain relative to the dimer domain 
between NapA and NhaA. With reference to the dimerisation interface, which is 
shown from cryo-EM studies not to change appreciably in response to Na+ binding 
(Vinothkumar et al., 2005; Appel et al., 2009), the core domain in the NhaA structure 
can be rotated by 21° relative to the core of NapA. This large rotation of the core 
domain closes the cavity seen on the outside of NapA and opens the cytoplasmic 
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funnel on the inside, as observed in NhaA. During this process the proposed single 
cation binding aspartate (Asp157/Asp164) is shifted 10 Å towards the cytoplasmic 
surface of the transporter (figure 6.3). 
 
 
Figure 6.3 – Alternating access model of Na+/H+ antiport. Schematic 
representation of the proposed mechanism illustrating the conformational changes, 
that of the core moving against the dimerisation domain, showing the transition from 
the outward-open (left) to the inward-open state (right). During this process the 
location of ion binding aspartate residue (Asp157/Asp164), shown in red, moves 
some 10 Å towards the cytoplasmic surface. 
 
This elevator movement of a substrate-binding core domain, in this case to carry Na+ 
ions from one side of the membrane to the other, resembles that of the two-domain 
rocking bundle movements seen in the transport mechanism of the Na+-coupled 
glutamate transporter GltPh (Reyes et al., 2009)(figure 6.4) and has also been proposed 
for the structural NhaA homologue AsbTNM (Hu et al., 2011). Interestingly, a two 
domain transport mechanism was also recently predicted in NhaA, based on a 
consideration of the two symmetry related inverted repeats as well as elastic network 
models and biochemical cross-linking (Schushan et al., 2012). It was also noticed that 
the position of Asp164 from this NhaA model points towards the outward-facing 
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cavity, similar to the equivalent Asp157 residue in the outward-facing NapA 
structure. 
 
(a) 
 
(b) 
 
Figure 6.4 – Two-domain rocking bundle model of NapA and GltPh. (a) Cartoon 
representation of the outward-facing NapA structure (left) and inward-facing NapA 
model (right), which was constructed by reorientation of the core domain (blue) to the 
same position as the core domain in the inward-facing NhaA structure relative to the 
fixed position of the dimer domain (beige). Asp157 is shown as a stick and modelled 
to coordinate a sodium ion (pink sphere) between the two states. (b). The crystal 
structures of GltPh, solved in the outward (PDB: 2NWX; (Boudker et al., 2007)) and 
inward-occluded (PDB: 3KBC; (Reyes et al., 2009)) states, shown in the same format 
as NapA with two coordinated sodium ions (pink spheres). Position of the membrane 
is shown by a grey line.
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7.0 - Concluding Remarks 
 
The work from this thesis has enabled us to describe global conformational changes 
that make up the alternating access model of Na+/H+ antiport. Surprisingly, the 
conformational change between the inward NhaA state and outward NapA state are 
very large. It therefore seems that the rate of secondary active transport may not 
necessarily correlate with the size of the conformational change or the substrate itself, 
as previously assumed. Although we have not been able to resolve sodium binding, 
the NhaA and NapA structures are consistent with a single ion-translocation site 
mechanism, of which a strictly conserved aspartate residue (Asp157/Asp164 in 
NapA/NhaA) is solvent accessible in both opposing conformations. Further structures 
and methods that capture membrane dynamics are however needed to clarify how the 
local ion binding and release are coupled to these global changes now outlined in this 
thesis.
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Appendix I 
 
MemGold™ screen (Hamptons Research) 
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Appendix II 
 
 
Table 7 – Expression screening of NhaA mutants using MemStar. All mutants 
contain the Ala109Thr mutation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix III 
 
The experimental work of this thesis is presented in the following manuscripts; 
 
Chapter 3 
 
Lee C, Kang HJ, Hjelm A, Choudhury H, Beis K, de Gier JW, Drew D. 
MemStar: A new strategy for membrane protein production in E. coli. (Manuscript in 
preparation). 
 
Chapter 4 
 
Drew D, Beckstein O, Lee C, Yashiro S, Sansom M, Iwata S, Cameron A.D. 
A salt-bridge in the sodium-proton antiporter NhaA acts as a sodium-sensitive 
electrostatic switch. (Manuscript in preparation). 
 
Chapter 5 
 
Lee C, Kang HJ, von Balmoos C, Newstead S, Uzdavinys P, Iwata S, Beckstein O, 
Cameron A.D., Drew D (2013) A two-domain elevator mechanism for sodium/proton 
antiport. Nature, (Manuscript under revision). 
NhaA mutant Standard (mg. L-1) MemStar (mg. L-1)
Gln277His 14 135
Gln277Ala 13 123
Gln277Ser 14 137
Gln277Gly 11 126
Gln277Leu 16 111
Gln277Asp 13 131
